<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Purinergic Signal</journal-id>
      <journal-title>Purinergic Signalling</journal-title>
      <issn pub-type="ppub">1573-9538</issn>
      <issn pub-type="epub">1573-9546</issn>
      <publisher>
        <publisher-name>Springer Netherlands</publisher-name>
        <publisher-loc>Dordrecht</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18404442</article-id>
      <article-id pub-id-type="pmc">2072922</article-id>
      <article-id pub-id-type="publisher-id">9065</article-id>
      <article-id pub-id-type="doi">10.1007/s11302-007-9065-z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Adenosine A<sub>1</sub> receptor: Functional receptor-receptor interactions in the brain</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sichardt</surname>
            <given-names>Kathrin</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Nieber</surname>
            <given-names>Karen</given-names>
          </name>
          <address>
            <phone>+49-341-9736812</phone>
            <fax>+49-341-9736898</fax>
            <email>nieber@rz.uni-leipzig.de</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Institute of Pharmacy, University of Leipzig, Talstr. 33, 04103 Leipzig, Germany </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>5</day>
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>9</month>
        <year>2007</year>
      </pub-date>
      <volume>3</volume>
      <issue>4</issue>
      <fpage>285</fpage>
      <lpage>298</lpage>
      <history>
        <date date-type="received">
          <day>23</day>
          <month>7</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>24</day>
          <month>7</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Springer Science + Business Media B.V. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Over the past decade, many lines of investigation have shown that receptor-mediated signaling exhibits greater diversity than previously appreciated. Signal diversity arises from numerous factors, which include the formation of receptor dimers and interplay between different receptors. Using adenosine A<sub>1</sub> receptors as a paradigm of G protein-coupled receptors, this review focuses on how receptor-receptor interactions may contribute to regulation of the synaptic transmission within the central nervous system. The interactions with metabotropic dopamine, adenosine A<sub>2A</sub>, A<sub>3</sub>, neuropeptide Y, and purinergic P2Y<sub>1</sub> receptors will be described in the first part. The second part deals with interactions between A<sub>1</sub>Rs and ionotropic receptors, especially GABA<sub>A</sub>, NMDA, and P2X receptors as well as ATP-sensitive K<sup>+</sup> channels. Finally, the review will discuss new approaches towards treating neurological disorders.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>Adenosine</kwd>
        <kwd>G protein-coupled receptors</kwd>
        <kwd>Receptor interactions</kwd>
        <kwd>Neurotransmission</kwd>
        <kwd>Adenosine receptors</kwd>
        <kwd>Ionotropic receptors</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Science+Business Media B.V. 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>The vertebrate central nervous system (CNS) is characterized by a dynamic interplay between signal transduction molecules and their cellular targets. Modulation of synaptic transmission by metabotropic or ionotropic receptors is an important source of control and dynamical adjustment in synaptic activity.</p>
      <p>Recent studies have provided new insights into the role of ligand-gated ion channels in modifying synaptic transmission. Along with a growing list of different types of pre- and postsynaptic ionotropic receptors and the cell types that express them, there have also been advances in characterizing the modulatory mechanisms of the receptors that link to receptor activation. This is important due to the convergence of data from biochemical, molecular, and electrophysiological studies, implicating ionotropic receptors in the effects of psychoactive and addictive drugs.</p>
      <p>G protein-coupled receptors (GPCRs) make up the largest and most diverse family of membrane receptors in the human genome, relaying information on the presence of diverse extracellular stimuli to the cell interior. An estimated 1% of the mammalian genome encodes for GPCRs, and about 450 of the approximately 950 predicted human GPCRs are thought to be receptors for endogenous ligands [<xref ref-type="bibr" rid="CR1">1</xref>]. The manipulation of transmembrane signaling by GPCRs may constitute the most important therapeutic target in medicine. Nearly 40% of all current therapeutic drugs target GPCRs [<xref ref-type="bibr" rid="CR2">2</xref>].</p>
      <p>All known GPCRs share a common architecture of seven membrane-spanning helices connected by intracellular and extracellular loops. Drugs acting on GPCRs have been classified as agonists, partial agonists, or antagonists based on a &#x201C;two-state model of receptor function.&#x201D; Since experimental evidence pointed out the impossibility of explaining the operation of GPCRs without considering dimers as the minimum structure for many GPCRs the &#x201C;two-state dimer receptor model&#x201D; was developed based on the communication between the two subunits of the receptor dimmer [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. This model is an extension of the &#x201C;two-state model of receptor function&#x201D; but considers dimeric structures able to bind one molecule to the orthosteric center in each monomer.</p>
      <p>GPCR signaling is subject to extensive negative regulation through receptor desensitization, sequestration, and downregulation, termination of G protein activation by GTPase-activating proteins, and enzymatic degradation of second messengers. Additional protein-protein interactions positively modulate GPCR signaling by influencing ligand binding and specificity.</p>
      <p>Multiprotein complexes mediate most cellular functions. In neurons, these complexes are directly involved in the neuronal transmission, which is responsible for learning, memory, and developments. The first publication in this direction came from H&#xF6;kfelt&#x2019;s group in 1983. The publication describes how substance P may modulate the high-affinity serotonin (5-HT) binding site in a spinal cord membrane preparation [<xref ref-type="bibr" rid="CR5">5</xref>]. Over the past decade, the number and outcomes of interactions between receptors have increased continuously [<xref ref-type="bibr" rid="CR6">6</xref>]. Recent studies have demonstrated close physical interactions where activation of one receptor affects the function of the other.</p>
      <p>Adenosine is an endogenous purine nucleoside that has evolved to modulate many physiological processes. Extracellular adenosine mostly originates from release of intracellular adenosine and from release and extracellular breakdown of cAMP and ATP by ecto-5&#x2032;-nucleotidase and phosphodiesterase [<xref ref-type="bibr" rid="CR7">7</xref>]. Cellular signaling by adenosine occurs through four known adenosine receptor subtypes (A<sub>1</sub>Rs, A<sub>2A</sub>Rs, A<sub>2B</sub>Rs, and A<sub>3</sub>Rs), all of which are seven-transmembrane-spanning GPCRs. Of the four known adenosine receptors, A<sub>1</sub>Rs and A<sub>2A</sub>Rs are primarily responsible for the central effects of adenosine, especially in modulating synaptic transmission [<xref ref-type="bibr" rid="CR8">8</xref>]. Adenosine can act on A<sub>1</sub>Rs to depress transmitter release and neuronal sensitivity to the transmitter [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. As a result, the A<sub>1</sub>Rs are important in the regulation of synaptic plasticity, playing a role in determining the amplitude of long-term potentiation or long-term depression [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>There are numerous reviews that describe regulation of brain adenosine levels, adenosine receptors, their cellular and subcellular localization, signaling pathways, and function in the brain under physiological and pathophysiological conditions as well as selective receptor agonists and antagonists. Using A<sub>1</sub>Rs as a paradigm of GPCRs, this review focuses on how receptor-receptor interactions contribute to regulatory processes within the central nervous system.</p>
      <p>Considering the various types of receptors, one may expect to find three principle paths of receptor interaction: (1) interactions between ionotropic receptors, (2) interactions between a metabotropic receptor and an ionotropic receptor, and (3) interactions between metabotropic receptors. The examples mentioned below stem from the second and third type of interaction. Interactions with metabotropic dopamine receptors as well as A<sub>2A</sub>, A<sub>3</sub>, NPY, and P2Y<sub>1</sub> receptors will be described in the first part. The second part deals with interactions between A<sub>1</sub>Rs and ionotropic receptors, especially the GABA<sub>A</sub>, NMDA, and P2X receptors as well as ATP-sensitive K<sup>+</sup> channels. Finally, new approaches for neurological disorders will be discussed.</p>
    </sec>
    <sec id="Sec2">
      <title>Functional interactions with metabotropic receptors</title>
      <p>Two forms of GPCR classification exist. There is the historical division into three main families: (1) rhodopsin-like family which includes adenosine receptors, (2) secretin-like family, and (3) metabotropic glutamate receptor-like family. The families share some basic similarities&#x2014;the seven-transmembrane-spanning domains, intracellularly located C terminus, and extracellularly residing N terminus. Differences between the families arise in the length of the intracellular and extracellular termini and amino acid sequences, disulfide bridge linking, and conserved domains. Five different groups can be classified by applying phylogenetic analyses. The GRAFS system distinguishes between <bold>g</bold>lutamate, <bold>r</bold>hodopsin, <bold>a</bold>dhesion, <bold>f</bold>izzled/taste, and <bold>s</bold>ecretin-like GPCRs [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
      <p>The agonist binding on the receptor results in coupling to heterotrimeric G proteins and regulates a variety of cell responses. In brief, an exchange of G protein-bound GDP to GTP occurs, and the heterotrimer dissociates into the &#x3B1; subunit and the &#x3B2;&#x3C7; dimer. The resulting products activate or inhibit effectors independently from each other. Currently, 16 different genes encode G protein &#x3B1; subunits, five genes encode &#x3B2; subunits, while 14 genes encode &#x3C7; subunits [<xref ref-type="bibr" rid="CR13">13</xref>]. The &#x3B1; subunits can be categorized into four basic groups: the stimulatory <inline-formula id="IEq1"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq1.gif --><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{\alpha {\text{s}}}}  $$\end{document}</tex-math></inline-formula> family couples to adenylate cyclase and increases cAMP levels, whereas the inhibitory <inline-formula id="IEq2"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq2.gif --><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{{\alpha {\text{i}}} \mathord{\left/  {\vphantom {{\alpha {\text{i}}} 0}} \right.  \kern-\nulldelimiterspace} 0}}  $$\end{document}</tex-math></inline-formula> family acts in the opposite way. Moreover, the <inline-formula id="IEq3"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq3.gif --><tex-math id="M3">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{{\alpha {\text{q}}} \mathord{\left/  {\vphantom {{\alpha {\text{q}}} {11}}} \right.  \kern-\nulldelimiterspace} {11}}}  $$\end{document}</tex-math></inline-formula> family activates the phospholipase <inline-formula id="IEq4"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq4.gif --><tex-math id="M4">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{C}}_{\beta }  $$\end{document}</tex-math></inline-formula> (<inline-formula id="IEq5"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq5.gif --><tex-math id="M5">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{PLC}}_{\beta }  $$\end{document}</tex-math></inline-formula>), and lastly, the <inline-formula id="IEq6"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq6.gif --><tex-math id="M6">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{\alpha {12} \mathord{\left/  {\vphantom {{12} {13}}} \right.  \kern-\nulldelimiterspace} {13}}}  $$\end{document}</tex-math></inline-formula> family which regulates Rho proteins. <inline-formula id="IEq7"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq7.gif --><tex-math id="M7">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{\beta \chi }}  $$\end{document}</tex-math></inline-formula> dimers are capable of triggering effects on inward rectifier K<sup>+</sup> channels (GIRK<sub>1&#x2013;4</sub>), voltage-dependent Ca<sup>2+</sup> channels (VDCC), and phospholipase A<sub>2</sub> (PLA<sub>2</sub>), <inline-formula id="IEq8"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq8.gif --><tex-math id="M8">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{PLC}}_{\beta }  $$\end{document}</tex-math></inline-formula>, and the Na<sup>+</sup>/H<sup>+</sup> exchanger (NHE1). Thus, it is not surprising that GPCRs are such interesting candidates in current drug research with their amazing potential in affecting signaling events. A single GPCR possesses the potential to activate more than just one signaling pathway [<xref ref-type="bibr" rid="CR12">12</xref>]; for example, activation of A<sub>1</sub>Rs includes coupling to <inline-formula id="IEq9"><!-- Alternate image not processed: 11302_2007_9065_Article_IEq9.gif --><tex-math id="M9">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{{\alpha {\text{i}}} \mathord{\left/  {\vphantom {{\alpha {\text{i}}} 0}} \right.  \kern-\nulldelimiterspace} 0}}  $$\end{document}</tex-math></inline-formula> and increasing of IP3 level [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Furthermore, homodimerization and heterodimerization are common paths of interaction and have been described in A<sub>1</sub>Rs and the A<sub>2</sub>Rs several times [<xref ref-type="bibr" rid="CR16">16</xref>&#x2013;<xref ref-type="bibr" rid="CR18">18</xref>]. In addition, functional interactions on the A<sub>1</sub>R without receptor assembling have already been revealed [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], or are currently being elucidated. The next paragraphs will deal with a few selected examples of this limitlessly wide topic.</p>
      <sec id="Sec3">
        <title>Relationship between A<sub>1</sub>Rs and A<sub>3</sub>Rs</title>
        <p>The A<sub>3</sub>R was the latest receptor subtype of the adenosine receptor family to be identified [<xref ref-type="bibr" rid="CR21">21</xref>], and its functional role is still controversially discussed. Several findings indicate neuroprotective as well as neurotoxic action depending on experimental approach [<xref ref-type="bibr" rid="CR22">22</xref>&#x2013;<xref ref-type="bibr" rid="CR29">29</xref>]. A<sub>3</sub>Rs couple to inhibition of adenylyl cyclase as well as to activation of PLC, and to elevation of inositol triphosphate levels [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Furthermore, an increase in intracellular Ca<sup>2+</sup> levels due to release from intracellular stores and Ca<sup>2+</sup> influx has been described [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. One interesting example of A<sub>3</sub>Rs&#x2019; functional role is their involvement in acute neurotoxic situations and interplay with A<sub>1</sub>Rs. Dunwiddie et al. [<xref ref-type="bibr" rid="CR34">34</xref>] reported on the potential of A<sub>3</sub>Rs to modify responses via A<sub>1</sub>Rs in the hippocampus. The activation of hippocampal A<sub>3</sub>Rs induced a desensitization of A<sub>1</sub>Rs on combined superfusion of Cl-IB-MECA and adenosine. This phenomenon was thought to reduce the protective effects of endogenous adenosine caused by the lack of sensitivity of A<sub>1</sub>Rs. Further investigations on pyramidal cells of the rat cingulate cortex did not confirm Dunwiddie et al.&#x2019;s assumption [<xref ref-type="bibr" rid="CR35">35</xref>]. In this brain area, A<sub>1</sub>Rs and A<sub>3</sub>Rs did not show any interaction. The receptor subtypes were unable to affect each other. The discrepancy was taken to be a genetic phenomenon, such as alternative splicing of the rat A<sub>3</sub>R transcript causing distinguished pharmacological and functional properties in the brain. Furthermore, Hentschel et al. [<xref ref-type="bibr" rid="CR36">36</xref>] demonstrated the involvement of A<sub>3</sub>Rs in inhibition of excitatory neurotransmission during hypoxic conditions, indicating a neuroprotective action of endogenously released adenosine on A<sub>3</sub>Rs in addition to A<sub>1</sub>Rs. Lastly, Lopes et al. [<xref ref-type="bibr" rid="CR37">37</xref>] attempted to define the possible role of A<sub>3</sub>Rs in the rat hippocampus using experiments similar to those of Dunwiddie et al. in non-stressful and stressful situations, with particular attention to whether A<sub>3</sub>Rs control A<sub>1</sub>Rs. These data suggested that no interaction between the two receptor subtypes exist, but confirm that A<sub>3</sub>Rs do not affect synaptic transmission on superfusion with A<sub>3</sub>R agonist Cl-IB-MECA or A<sub>3</sub>R antagonist MRS 1191. The authors pointed out that Cl-IB-MECA binds to A<sub>1</sub>Rs even at low nanomolar concentrations. Thus, the existence of an interaction between A<sub>1</sub>Rs and A<sub>3</sub>Rs has to wait for reliable ligands.</p>
      </sec>
      <sec id="Sec4">
        <title>Antagonistic interaction between A<sub>1</sub>Rs and A<sub>2A</sub>Rs</title>
        <p>A<sub>2A</sub>Rs are widely distributed in the CNS, but local and subcellular differences in allocation exist. They show high levels in all subregions of the striatum and in the globus pallidus. A<sub>2A</sub>Rs are also expressed in neurons in the neocortex and limbic cortex, but at a density a twentieth of that found in basal ganglia [<xref ref-type="bibr" rid="CR38">38</xref>]. Colocalization of A<sub>1</sub>Rs and A<sub>2A</sub>Rs was approved for glutamatergic nerve terminals in the hippocampus [<xref ref-type="bibr" rid="CR39">39</xref>]. In the striatum, A<sub>1</sub>R/A<sub>2A</sub>R heteromers were found on synapses with spines of medium spiny neurons and integrated in the presynaptic membrane of glutamatergic terminals that represent the cortical-limbic-thalamic input [<xref ref-type="bibr" rid="CR18">18</xref>]. A<sub>1</sub>Rs and A<sub>2A</sub>Rs modulate excitatory synaptic transmission, albeit in an opposite manner. A<sub>1</sub>R activation inhibited glutamatergic synaptic transmission mainly through presynaptic inhibition of glutamate release, while A<sub>2A</sub>Rs have been shown to facilitate glutamatergic synaptic transmission [<xref ref-type="bibr" rid="CR40">40</xref>&#x2013;<xref ref-type="bibr" rid="CR42">42</xref>]. At first sight, stimulating A<sub>1</sub>Rs and inhibiting A<sub>2A</sub>Rs may have a neuroprotective influence on the mature CNS. However, problems arise due to long-term desensitization of A<sub>1</sub>Rs. A<sub>2A</sub>Rs do not upregulate after antagonist administration, but have a low abundance in hippocampal and cortical areas compared with A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. A<sub>1</sub>Rs and A<sub>2A</sub>Rs cannot be regarded in isolation from one another since cross talk between the subtypes has been described several times [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR45">45</xref>&#x2013;<xref ref-type="bibr" rid="CR47">47</xref>]. A<sub>2A</sub>R activation by agonists caused A<sub>1</sub>R desensitization resulting in decreased binding affinity for CPA in the hippocampus in young adult rats. Controlling A<sub>1</sub>Rs by A<sub>2A</sub>Rs was mediated by protein kinase C in a cAMP-independent manner. A<sub>2A</sub>R activation was seen to play a role in fine-tuning A<sub>1</sub>Rs by attenuating the tonic effect of presynaptic A<sub>1</sub>Rs located on glutamatergic nerve terminals [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. In the striatal system, A<sub>1</sub>R/A<sub>2A</sub>R heteromers became prominent to show an antagonistic reciprocal interaction [<xref ref-type="bibr" rid="CR18">18</xref>]. As in the hippocampus, A<sub>2A</sub>R stimulation decreased the affinity of A<sub>1</sub>Rs for agonists. The A<sub>1</sub>R/A<sub>2A</sub>R heteromer allows adenosine to perform a detailed modulation of glutamate release [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Regarding A<sub>1</sub>Rs and A<sub>2A</sub>Rs, basal conditions generate a low tone of endogenous adenosine and cause A<sub>1</sub>R activation, in contrast to situations of increased adenosine where A<sub>2A</sub>R activation becomes dominant. When adenosine concentrations rise, as during anoxia, likely also time appears to be important in regulating A<sub>2A</sub> receptor activity, which means A<sub>2A</sub> receptors are &#x201C;active&#x201D; under prolonged stimulation [<xref ref-type="bibr" rid="CR49">49</xref>]. Finally, activation of the A<sub>1</sub>R/A<sub>2A</sub>R heteromer contributes to A<sub>2A</sub>R signaling when adenosine levels are elevated and may provide a mechanism to facilitate plastic changes in the excitatory synapse [<xref ref-type="bibr" rid="CR18">18</xref>].</p>
      </sec>
      <sec id="Sec5">
        <title>Interactions between adenosine and dopaminergic system</title>
        <p>Dopamine is an important transmitter in basal ganglia and is noted for influencing motor activity, playing an important role in Parkinson&#x2019;s disease. Adenosine-dopamine interactions are complex and cannot be limited on functional considerations of A<sub>1</sub>Rs. Intramembrane heteromeric receptor-receptor interactions and the involvement of A<sub>2A</sub>Rs in influencing dopaminergic signaling have to be mentioned due to the implications in the treatment of Parkinson&#x2019;s disease. Gin&#xE9;s et al. [<xref ref-type="bibr" rid="CR50">50</xref>] described the formation of functionally interacting heteromeric complexes between dopamine D<sub>1</sub> receptors (D<sub>1</sub>Rs) and A<sub>1</sub>Rs in mouse fibroblast Ltk&#x2212; cells cotransfected with respective cDNAs. Coaggregation occurred when cells were pretreated with R-PIA as A<sub>1</sub>R agonist, but was decreased by combined pretreatment with R-PIA and SKF-38393, a D<sub>1</sub>R agonist. Furthermore, the D<sub>1</sub>R agonist-induced cAMP accumulation was reduced by combined pretreatment of D<sub>1</sub>R- and A<sub>1</sub>R agonist, but remained unaffected when given alone, respectively. The results confirmed an antagonistic interaction between A<sub>1</sub>Rs and D<sub>1</sub>Rs that had already been observed by Ferr&#xE9; et al. [<xref ref-type="bibr" rid="CR51">51</xref>] in behavioral studies using reserpinized mice and rabbits. In vivo and in vitro data on adenosine-dopamine interactions were mostly obtained from investigations in the basal ganglia and limbic regions [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>] due to the high abundance of A<sub>1</sub>Rs, A<sub>2</sub>ARs, D<sub>1</sub>Rs, and D<sub>2</sub>Rs in these areas and their involvement in the pathology of Parkinson&#x2019;s disease. The antagonistic interaction of combined receptor activation seems to distinguish between adenosine and dopamine receptor subtypes. While A<sub>1</sub>Rs communicate mainly with the D<sub>1</sub>R subtype in strionigral-strioentopenduncular neurons, A<sub>2A</sub>R and D<sub>2</sub>R interaction occurs in striopallidal neurons. Studies on mice and monkeys pretreated with MPTP suggest that some degree of dopaminergic activity is needed to obtain adenosine antagonistic-induced motor activity. Furthermore, blockade of dopaminergic neurotransmission counteracts the antagonistic effect induced by adenosine [<xref ref-type="bibr" rid="CR54">54</xref>]. Sufficient endogenous adenosine is present interstitially in the substantia nigra pars reticulata to control dopaminergic effects. The effects of adenosine are absent when dopaminergic influence is suppressed [<xref ref-type="bibr" rid="CR53">53</xref>]. Thus, it seems that monotherapy with A<sub>2A</sub>R antagonists may only be useful in the early stages of Parkinson&#x2019;s disease, but could support a therapeutic treatment with dopamine agonists in advanced stages. A promising approach using these therapeutic strategies can be seen in istradefylline, an A<sub>2A</sub>R antagonist that has since successfully passed clinical trials [<xref ref-type="bibr" rid="CR55">55</xref>]. However, A<sub>1</sub>R blockade may also contribute to an increased dopamine release but this effect seems without clinical relevance.</p>
      </sec>
      <sec id="Sec6">
        <title>Relationship between A<sub>1</sub>Rs and NPY</title>
        <p>Neuropeptide Y (NPY) is one of the most abundant neuropeptides and exerts various functions on at least six GPCR subtypes (Y<sub>1</sub>Rs-Y<sub>5</sub>Rs, y<sub>6</sub>Rs). Immunohistochemical investigations revealed the appearance of the Y<sub>1</sub>R and Y<sub>5</sub>R subtypes in the rat frontal cortex [<xref ref-type="bibr" rid="CR56">56</xref>&#x2013;<xref ref-type="bibr" rid="CR58">58</xref>]. Activation of NPY receptors results in an inhibition of excitatory synaptic transmission, while a presynaptic influence on cortical neurons has been postulated [<xref ref-type="bibr" rid="CR59">59</xref>]. NPY receptors affect pertussis toxin-sensitive G proteins, which inhibit adenylyl cyclase and decrease cAMP levels. Inhibitory and facilitating effects on K<sup>+</sup> and Ca<sup>2+</sup> mobilization have also been observed [<xref ref-type="bibr" rid="CR60">60</xref>]. Receptor-receptor interactions between Y<sub>1</sub>Rs have already been described, such as the antagonistic interaction with galanin receptors in the hypothalamus of the rat and their functional relevance for food intake. In contrast, a facilitatory interaction between the two receptors exists in the amygdala which may be of relevance for fear-related behavior [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
        <p>In the CNS, A<sub>1</sub>Rs and NPY receptors share some similarities in distribution. Both A<sub>1</sub>Rs and Y<sub>1</sub>Rs are located on neurons of the prefrontal cortex, and their activation inhibits glutamatergic neurotransmission [<xref ref-type="bibr" rid="CR62">62</xref>]. This is evidence for potential interaction between A<sub>1</sub>Rs and Y<sub>1</sub>Rs that may modulate long-term desensitization of A<sub>1</sub>Rs during pathophysiological situations. To investigate possible functional interactions, postsynaptic potentials (PSPs) were generated by electrical field stimulation on pyramidal neurons of layer V in the rat cingulate cortex as described by Brand et al. [<xref ref-type="bibr" rid="CR35">35</xref>] and Hentschel et al. [<xref ref-type="bibr" rid="CR36">36</xref>]. The Y<sub>1</sub>R agonist [F7,P34]pNPY inhibited the amplitude of PSPs. The inhibitory effect was reversible and reproducible, indicating that no desensitization appeared (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>a). An additional decrease in PSP amplitude was observed when NPY was superfused in combination with the A<sub>1</sub>R agonist CPA (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>b).
<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Effect of the selective Y<sub>1</sub> agonist [F7,P34]pNPY as well as neuropeptide Y (NPY) alone and in combination with selective A<sub>1</sub>R agonist <italic>N</italic><sup>6</sup>-cyclopentyladenosine (CPA) on the amplitude of postsynaptic potentials (PSPs) evoked by electrical field stimulation (0.2 Hz, 2&#xA0;ms) in layer I of the rat cingulate cortex (Sichardt et al., unpublished results). Intracellular recordings were performed in rat brain slices using glass microelectrodes placed in pyramidal cells of layer V. <bold>a</bold> [F7,P34]pNPY superfused for 5&#xA0;min inhibits reversibly the PSPs by 34.6&#x2009;&#xB1;&#x2009;8%. Y<sub>1</sub> antagonist BIBP3226 itself reduces the PSP by 23&#x2009;&#xB1;&#x2009;10%, whereas [F7,P34]pNPY has no inhibitory effect in the presence of the antagonist. <bold>b</bold> NPY depresses PSPs by 28.6&#x2009;&#xB1;&#x2009;0.7%. The combined superfusion of NPY and CPA resulted in an additional depression of the PSPs by 48.1&#x2009;&#xB1;&#x2009;5%. The depressant effects of the two agonists were reversible during washout. Data are expressed as mean &#xB1; SEM from <italic>n</italic>&#x2009;=&#x2009;3 independent experiments. *<italic>p</italic>&#x2009;&lt;&#x2009;0.05 significant vs control; <sup>#</sup><italic>p</italic>&#x2009;&lt;&#x2009;0.05 significant vs NPY alone</p></caption><graphic position="anchor" xlink:href="11302_2007_9065_Fig1_HTML" id="MO1"/></fig></p>
        <p>The additional inhibition induced by CPA was in the same range as that found with CPA alone (48.1&#x2009;&#xB1;&#x2009;5% vs 55&#x2009;&#xB1;&#x2009;3%). NPY inhibited PSPs after blockading CPA-mediated inhibitory effects by DPCPX. No significant changes existed before and after blockading A<sub>1</sub>Rs (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>). The results suggest that no interaction between A<sub>1</sub>Rs and Y<sub>1</sub>Rs exist. Each neuromodulator contributes to inhibitory regulation of excitatory neurotransmission. Regarding the desensitization of A<sub>1</sub>Rs but not of Y<sub>1</sub>Rs, this may be important under pathophysiological conditions with increased adenosine concentration in the synaptic cleft.
<fig id="Fig2"><label>Fig.&#xA0;2</label><caption><p>Effect of neuropeptide Y (NPY) on the PSPs alone and in combination with the selective A<sub>1</sub>R agonist <italic>N</italic><sup>6</sup>-cyclopentyladenosine (CPA) after preincubation with the selective A<sub>1</sub>R antagonist 1,3-dipropyl-8-cyclopentylxantine (DPCPX) (Sichardt et al., unpublished results). The experimental procedure was similar to that shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>. In the presence of NPY, PSPs were decreased by 35.4&#x2009;&#xB1;&#x2009;7%. Combined superfusion of NPY and CPA after preincubation with DPCPX decreased PSPs by 32.7&#x2009;&#xB1;&#x2009;8%. The depression was reversible during washout. Data are expressed as mean &#xB1; SEM from <italic>n</italic>&#x2009;=&#x2009;5 independent experiments. *<italic>p</italic>&#x2009;&lt;&#x2009;0.05 significant vs control; <sup>#</sup><italic>p</italic>&#x2009;&lt;&#x2009;0.05 significant vs superfusion of CPA and DPCPX</p></caption><graphic position="anchor" xlink:href="11302_2007_9065_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec7">
        <title>Interaction of A<sub>1</sub>Rs and P2Y<sub>1</sub>Rs</title>
        <p>P2Y<sub>1</sub>Rs have been cloned and characterized in several species including human and rat, whereas mRNA was detected in various regions of the brain. The receptor subtype can be activated by ATP, but ADP as a degradation product of ATP is a more potent endogenous agonist. Cellular signaling differs between A<sub>1</sub>Rs and P2Y<sub>1</sub>Rs since A<sub>1</sub>Rs couple to G<sub>i/0</sub> and P2Y<sub>1</sub>Rs to G<sub>q</sub>/G<sub>11</sub>. In fact, P2Y<sub>1</sub>Rs can be assumed to exert stimulatory effects in cells. P2Y<sub>1</sub>R signaling occurs in non-neuronal and non-muscular cell types, as well as on neurons in the CNS [<xref ref-type="bibr" rid="CR63">63</xref>] where a colocalization of A<sub>1</sub>Rs and P2Y<sub>1</sub>Rs was demonstrated immunohistochemically in rat brain cortex, hippocampus, and cerebellum [<xref ref-type="bibr" rid="CR64">64</xref>]. In 1996, Ikeuchi et al. reported the activation of an undefined P2YR by adenosine in patch clamp and calcium imaging experiments on hippocampal neurons [<xref ref-type="bibr" rid="CR65">65</xref>]. Furthermore, extensive heteromerization experiments have been conducted on cotransfected HEK293 cells using immunoprecipitation, Western blotting, and bioluminescence resonance energy transfer (BRET). Receptor binding experiments in combination with cAMP assays have also been described [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR66">66</xref>&#x2013;<xref ref-type="bibr" rid="CR70">70</xref>]. These respective studies confirmed heteromerization associated with changes in the agonist binding and signaling compared to monomer properties. The binding for selective A<sub>1</sub>R agonists was decreased while the A<sub>1</sub>R antagonist binding remained unaffected. Interestingly, ADP binding was blocked by DPCPX but not by the P2Y<sub>1</sub>R antagonist, suggesting an altered binding pocket on the A<sub>1</sub>R/P2Y<sub>1</sub>R complex. The G protein-coupling was sensitive to pertussis toxin and revealed a G<sub>i/0</sub> status for the heteromer. Although colocalization of A<sub>1</sub>Rs and P2Y<sub>1</sub>Rs in several brain areas has been demonstrated, there is still a lack of functional investigations. Nevertheless, the physiological relevance of this interaction has been postulated as follows: costorage and release of ATP with neurotransmitters, such as glutamate or noradrenaline, occurs in the CNS [<xref ref-type="bibr" rid="CR71">71</xref>&#x2013;<xref ref-type="bibr" rid="CR73">73</xref>]. ADP, the degradation product of ATP, acts as an A<sub>1</sub>R agonist due to the activation of the A<sub>1</sub>R/P2Y<sub>1</sub>R complex and contributes to the inhibitory modulation of excitatory synaptic transmission via adenosine acting on A<sub>1</sub>Rs. This interaction can be assumed as an additional mechanism for influencing and fine-tuning synaptic neurotransmission.</p>
      </sec>
    </sec>
    <sec id="Sec8">
      <title>Functional interaction with ionotropic receptors</title>
      <p>Neuronal excitability is regulated by voltage and ligand-gated ion channels. Ionotropic receptors also referred to as ligand-gated ion channels (LGICs) are a group of intrinsic transmembrane ion channels that open and close in response to binding of a chemical messenger, as opposed to voltage-gated ion channels or stretch-activated ion channels. Ion channels are regulated by a ligand and are usually very selective to one or more ions such as Na<sup>+</sup>, K<sup>+</sup>, Ca<sup>2+</sup>, or Cl<sup>&#x2212;</sup>. These receptors located at synapses convert the chemical signal of presynaptically released neurotransmitter directly and very quickly into a postsynaptic electrical signal. Many LGICs are additionally modulated by allosteric ligands by channel blockers, ions, or membrane potential.</p>
      <p>Nicotinic acetylcholine receptor serves as the prototypical LGIC [<xref ref-type="bibr" rid="CR74">74</xref>] and consists of a pentamer of protein subunits with two binding sites, which, when bound, alter the receptor configuration and cause an internal pore to open. This pore, permeable to Na<sup>+</sup> ions, allows them to flow down their electrochemical gradient into the cell. With a sufficient number of channels opening at once, the intracellular Na<sup>+</sup> concentration rises to the point at which the positive charge within the cell is sufficient to depolarize the membrane, and an action potential is initiated [<xref ref-type="bibr" rid="CR75">75</xref>]. Many important ion channels are ligand-gated, and they show a great degree of homology at the genetic level. The LGICs are classified into three superfamilies; the first&#x2014;the Cys-loop receptor family&#x2014;is subdivided into the anionic GABA<sub>A</sub> and glycine receptors on the one hand, and cationic 5-HT<sub>3</sub> serotonin and nicotinic acetylcholine receptors on the other. The second group&#x2014;ionotropic glutamate receptors&#x2014;consists of NMDA, kainate, and AMPA receptors. The third group covers the ATP-gated channels&#x2014;the P2X receptors [<xref ref-type="bibr" rid="CR76">76</xref>].</p>
      <p>Adenosine is known to inhibit glutamatergic neurotransmission by activation of presynaptic A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR35">35</xref>]. This is probably due to reduction of the calcium influx, possibly by modulating both P/Q- and N-type presynaptic voltage-dependent calcium channels, which in turn controls transmitter release [<xref ref-type="bibr" rid="CR77">77</xref>]. Furthermore, A<sub>1</sub>Rs have long been known to mediate neuroprotection by reduction of excitatory effects at the postsynaptic level [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. In addition to its direct presynaptic and postsynaptic actions on neurons, A<sub>1</sub>R interaction with NMDA [<xref ref-type="bibr" rid="CR80">80</xref>&#x2013;<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR84">84</xref>], GABA<sub>A</sub> [<xref ref-type="bibr" rid="CR85">85</xref>&#x2013;<xref ref-type="bibr" rid="CR88">88</xref>], and P2X receptors [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR89">89</xref>&#x2013;<xref ref-type="bibr" rid="CR91">91</xref>] contributes to fine-tuning neuromodulation via adenosine.</p>
      <sec id="Sec9">
        <title>Interaction between A<sub>1</sub>Rs and NMDA receptors</title>
        <p>Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system. In most brain areas, glutamate mediates fast synaptic transmission by activating ionotropic receptors of the AMPA, kainate, and NMDA type. Additionally, NMDA receptors play a critical role in synaptic plasticity, synaptic development, and neurotoxicity. Recent studies suggest that some NMDA-mediated actions are altered or mediated by adenosine. Synaptic currents mediated by glutamate in rat substantia nigra pas reticulata neurons were reduced by adenosine acting via A<sub>1</sub>Rs. The inhibitory action was not mediated by a postsynaptic site since adenosine did not block currents evoked by local application of glutamate [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
        <p>NMDA is known to increase the extracellular level of adenosine via bidirectional adenosine transporters or from released adenine nucleotides degraded by a chain of ectonucleotidases [<xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR93">93</xref>]. On the other hand, endogenous adenosine present in the extracellular fluid of hippocampal slices tonically inhibits NMDA receptor-mediated dendritic spikes as well as AMPA/kainate receptor-mediated synchronized EPSPs by activation of A<sub>1</sub>Rs in CA1 pyramidal cells [<xref ref-type="bibr" rid="CR81">81</xref>]. In line with these results, it has been shown that the tonic activation of A<sub>1</sub>Rs by ambient adenosine depressed field potentials in the striatum. The effect of adenosine in the striatum [<xref ref-type="bibr" rid="CR84">84</xref>] or hippocampus [<xref ref-type="bibr" rid="CR94">94</xref>] has not been found in A<sub>1</sub>R knockout mice and clearly demonstrates the involvement of A<sub>1</sub>Rs. The involvement of A<sub>1</sub>Rs was also supported by experiments using the selective receptor ligand 2-CA. In isolated rat hippocampal pyramidal cells [<xref ref-type="bibr" rid="CR95">95</xref>] and in bipolar cells of the retina [<xref ref-type="bibr" rid="CR96">96</xref>], 2-CA decreased inward currents induced by iontophoretic application of NMDA.</p>
        <p>Another interesting interaction concerns NMDA preconditioning to protect against glutamate neurotoxicity. The A<sub>1</sub>R antagonist 8-CPT has been shown to prevent neuroprotection evoked by NMDA preconditioning against glutamate-induced cellular damage in cerebellar granule cells [<xref ref-type="bibr" rid="CR83">83</xref>]. In this study, the functionality of A<sub>1</sub>Rs was not affected by NMDA preconditioning, but this treatment promoted A<sub>2A</sub>R desensitization in concert with A<sub>1</sub>R activation [<xref ref-type="bibr" rid="CR83">83</xref>]. These results are in line with other studies indicating that adenosine downregulates excitatory and inhibitory synaptic transmission in several brain areas through activation of A<sub>1</sub>Rs and A<sub>2A</sub>R [<xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR98">98</xref>]. Furthermore, activation of A<sub>1</sub>Rs mediates reversal of long-term potentiation (LTP) produced by brief application of NMDA in hippocampal CA1 neurons [<xref ref-type="bibr" rid="CR99">99</xref>].</p>
        <p>Taken together, there are several ways in which adenosine may interact with NMDA-induced cellular events. Adenosine can affect glutamatergic transmission via both presynaptic and postsynaptic mechanisms by activating A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR78">78</xref>]. NMDA receptors and A<sub>1</sub>Rs interact to downregulate glutamate release presynaptically in pyramidal cells of the cingulate cortex [<xref ref-type="bibr" rid="CR35">35</xref>], neurons of the hippocampus [<xref ref-type="bibr" rid="CR100">100</xref>], and striatal neurons [<xref ref-type="bibr" rid="CR84">84</xref>]. Another putative mechanism is related to postsynaptic A<sub>1</sub>Rs; adenosine elevates the threshold to open NMDA receptor-operated channels by antagonizing membrane depolarization [<xref ref-type="bibr" rid="CR101">101</xref>].</p>
      </sec>
      <sec id="Sec10">
        <title>Interaction between A<sub>1</sub>Rs and GABA<sub>A</sub> receptors</title>
        <p>Fast synaptic inhibition in the brain and spinal cord is largely mediated by GABA<sub>A</sub> receptors that are also targeted by drugs such as benzodiazepines, barbiturates, neurosteroids, and some anesthetics. The modulation of their function will have important consequences for neuronal excitation [<xref ref-type="bibr" rid="CR102">102</xref>]. One accepted means of modifying the efficacy is a functional interaction with adenosine. Adenosine may have an effect on either presynaptic GABA release in interneurons and/or on postsynaptic GABA<sub>A</sub> receptors in projection neurons. The site of action may be studied electrophysiologically by inducing fast inhibitory postsynaptic potentials (IPSPs) or application of GABA directly onto the cell. Adenosine and selective A<sub>1</sub>R agonist CHA reduced the amplitude of the fast IPSP in lateral amygdala slice preparations. The effect of CHA was blocked by DPCPX, indicating the involvement of A<sub>1</sub>Rs. Additionally, adenosine did not block currents evoked by local application of GABA [<xref ref-type="bibr" rid="CR85">85</xref>]. Thus, the modulatory effect of adenosine on the GABAergic neurotransmission appears to take place on a presynaptic site by inhibiting GABA release from nerve terminals [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. The assumption that the activation of A<sub>1</sub>Rs can presynaptically modulate inhibitory postsynaptic responses agrees with findings in several brain areas, such as the thalamus [<xref ref-type="bibr" rid="CR87">87</xref>], suprachiasmatic and arcuate nucleus [<xref ref-type="bibr" rid="CR88">88</xref>], and substantia nigra pars compacta [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
        <p>There is some evidence that activation of A<sub>1</sub>Rs is also involved in GABA<sub>A</sub> receptor downregulation, implying a facilitation of the neurotransmission on a postsynaptic site. GABA but not adenosine evoked an inward current in rat sacral dorsal commissural neurons (SDCN). The GABA-induced current was significantly reduced be adenosine. CHA and DPCPX, but not selective ligands for A<sub>2A</sub>Rs, mimicked or blocked the inhibitory effect of adenosine, respectively [<xref ref-type="bibr" rid="CR103">103</xref>]. Adenosine and muscimol induced a concentration-dependent reduction in the amplitude of population potentials in hippocampal slices. Additionally, adenosine potentiated the ability of muscimol to inhibit evoked potentials, which were blocked by the A<sub>1</sub>R-selective antagonist 8-CPT. The effects of adenosine as well as muscimol were reduced by the chloride channel blocker DIDS, indicating the ability of adenosine to regulate the GABA<sub>A</sub> chloride channel by activation of A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR104">104</xref>].</p>
        <p>Sebastiao&#x2019;s group studied the mechanisms by which GABA modulates adenosine-mediated effects and found that endogenous GABA exerts an inhibitory effect through GABA<sub>A</sub> receptors via a predominant adenosine-mediated action in the hippocampus. The authors concluded that there is an A<sub>1</sub>R-mediated ability to inhibit synaptic transmission [<xref ref-type="bibr" rid="CR19">19</xref>]. Further, this study showed that the blockade of GABAergic inhibition induced the release of NO, which was able to potentiate the inhibitory action of adenosine. They therefore suggested that the modulation of the A<sub>1</sub>R-mediated response by activation of GABA<sub>A</sub> receptors occurs indirectly via NO [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
        <p>Activation of GABA<sub>A</sub> receptors is effective in limiting neuronal ischemic damage [<xref ref-type="bibr" rid="CR105">105</xref>] and endogenous adenosine that arises during hypoxia, and acts neuroprotectively partly by activating A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, the contribution and potential interactions of GABA and adenosine as modulators of synaptic transmission during hypoxia has been investigated. Activation of A<sub>1</sub>Rs inhibits the release of GABA from the ischemic cerebral cortex in vivo [<xref ref-type="bibr" rid="CR106">106</xref>]. In contrast, the administration of an A<sub>1</sub>R agonist in the hippocampus failed to affect the release of GABA during ischemia [<xref ref-type="bibr" rid="CR107">107</xref>]. In the light of these controversial results, the role of the two neuromodulators during hypoxia was investigated in the CA1 area of rat hippocampal slices using selective A<sub>1</sub>R antagonists [<xref ref-type="bibr" rid="CR108">108</xref>]. Indeed, activation of A<sub>1</sub>R and GABA<sub>A</sub> receptors is partly involved in the inhibition of synaptic transmission during hypoxia. The action of GABA becomes evident when A<sub>1</sub>Rs are blocked. Regarding the desensitization of A<sub>1</sub>Rs during hypoxia [<xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR110">110</xref>], it may be assumed that GABA<sub>A</sub>-mediated inhibition of the synaptic transmission is evident when the A<sub>1</sub>R is desensitized or downregulated [<xref ref-type="bibr" rid="CR108">108</xref>].</p>
        <p>Comodulation by A<sub>1</sub>Rs and GABA<sub>A</sub> receptors was also suggested in acute cerebellar ethanol-induced ataxia. Using GABA<sub>A</sub> and A<sub>1</sub>R agonists and antagonists, respectively, a functional similarity between GABA<sub>A</sub> receptors and A<sub>1</sub>Rs has been shown even though both receptor types are known to couple to different signaling systems [<xref ref-type="bibr" rid="CR111">111</xref>]. This provides conclusive evidence that A<sub>1</sub>Rs and GABA<sub>A</sub> receptors both play a comodulatory role in ethanol-induced cerebellar ataxia without any direct interaction.</p>
      </sec>
      <sec id="Sec11">
        <title>Functional interaction between A<sub>1</sub>Rs and P2X receptors</title>
        <p>P2X receptors are ligand-gated ion channel receptors; seven subunits (P2X<sub>1</sub>-P2X<sub>7</sub>) have been identified [<xref ref-type="bibr" rid="CR63">63</xref>]. The P2X receptor subunits show many differences in localization, pharmacology, kinetics, and signaling pathways [<xref ref-type="bibr" rid="CR112">112</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]. The P2X<sub>1</sub> to P2X<sub>6</sub> receptors have 379&#x2013;472 amino acids, with a predicted tertiary structure of transmembrane segments, a large extracellular loop and intracellular C  and N termini. The P2X<sub>2</sub>, P2X<sub>4</sub>, and P2X<sub>4</sub>/P2X<sub>6</sub> receptors appear to be the predominant neuronal types [<xref ref-type="bibr" rid="CR91">91</xref>]. These subunits may occur as homooligomers or as heterooligomeric assemblies of more than one subunit. The P2X<sub>7</sub> receptor has a similar structure, but with a much larger intracellular C terminus. This contrasts strikingly with any of the other known ligand-gated ionotropic receptors [<xref ref-type="bibr" rid="CR114">114</xref>]. P2X<sub>7</sub> subunits do not form heterooligomeric assemblies, but are involved in mediating apoptosis and necrosis in glial cells and possibly neurons.</p>
        <p>Interaction between adenosine receptor-mediated and P2 receptor-mediated effects have been shown to occur in neuronal and non-neuronal cells [<xref ref-type="bibr" rid="CR80">80</xref>]. Both adenosine and ATP induce astroglial cell proliferation and formation of reactive astrocytes [<xref ref-type="bibr" rid="CR89">89</xref>]. In hippocampus, adenosine and ATP are released on stimulation and are potent neuronal transmission inhibitors [<xref ref-type="bibr" rid="CR115">115</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. It should be pointed out that the interpretation of effects induced by both is difficult since ATP is degraded enzymatically to adenosine [<xref ref-type="bibr" rid="CR38">38</xref>]. Adenosine is formed by extracellular catabolism of released ATP via the ectonucleotidase pathway [<xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]. The role of the ectonucleotidases in forming adenosine is difficult to study since this system is extremely efficient, and it is difficult to block an enzyme system. The experimental paradigm used by Cunha et al. [<xref ref-type="bibr" rid="CR118">118</xref>] demonstrates that ATP has to be converted outside the cell into adenosine to exert its inhibitory effects on hippocampal synaptic transmission. The inhibitory effect of ATP was not modified by the P2 receptor antagonist suramin, but was attenuated by the ecto-5&#x2019;-nucleotidase inhibitor and was nearly prevented by the adenosine A<sub>1</sub>R antagonist DPCPX, whereas dipyridamole, an inhibitor of adenosine uptake, potentiated the inhibitory effect of ATP [<xref ref-type="bibr" rid="CR118">118</xref>]. These results offer evidence for localized catabolism of adenine nucleotides followed by substrate channeling to A<sub>1</sub>Rs. This localized catabolism may mask the adenosine-mediated ATP effect [<xref ref-type="bibr" rid="CR119">119</xref>]. Recently it was demonstrated that the exogenous application of ATP or ATP&#x3C7;S reduced the hippocampal neurotransmission. The inhibitory effect was blocked by the selective A<sub>1</sub>R antagonist DPCPX and was potentiated by different ecto-ATPase inhibitors [<xref ref-type="bibr" rid="CR120">120</xref>]. These results suggest that the synaptic inhibition may consist of an inhibitory purinergic component of ATP itself in addition to degradation to adenosine.</p>
      </sec>
    </sec>
    <sec id="Sec12">
      <title>Interaction with neuronal ATP-sensitive K<sup>+</sup> channels</title>
      <p>ATP-sensitive K<sup>+</sup> channels (K<sub>ATP</sub>) are widely expressed in the cytoplasmic membrane of neurons and couple cell metabolism to excitability [<xref ref-type="bibr" rid="CR121">121</xref>]. These channels are regulated by the intracellular ATP/ADP ratio [<xref ref-type="bibr" rid="CR122">122</xref>] and modulated by many endogenous mediators, including adenosine, via A<sub>1</sub>Rs. Activation of A<sub>1</sub>Rs inhibited the activity of inspiratory neurons in the brainstem by opening K<sub>ATP</sub> in neonatal mice [<xref ref-type="bibr" rid="CR123">123</xref>]. A<sub>1</sub>R stimulation promotes K<sub>ATP</sub> activity in principal dopamine neurons in the substantia nigra pars compacta [<xref ref-type="bibr" rid="CR124">124</xref>] and hippocampus [<xref ref-type="bibr" rid="CR125">125</xref>]. In contrast, one recent study has demonstrated that adenosine induces internalization of K<sub>ATP</sub>, resulting in a decrease in K<sub>ATP</sub>-mediated response in the hippocampus [<xref ref-type="bibr" rid="CR126">126</xref>]. The discrepancy might be due to the additional activation of A<sub>2A</sub>Rs by adenosine located in hippocampus, but not in the substantia nigra pars compacta [<xref ref-type="bibr" rid="CR127">127</xref>]. In addition to the inhibitory effect on the presynaptic site, the activation of A<sub>1</sub>Rs acts as an inhibitory modulator to electrical activity on the postsynaptic site, and this effect has been attributed to enhancement of K<sub>ATP</sub> activity. The modulating effect on the membrane potential may differ depending on the brain regions, as neuronal K<sub>ATP</sub> is heterogeneous in different neurons.</p>
    </sec>
    <sec id="Sec13">
      <title>A<sub>1</sub>R interactions&#x2014;new approaches for neurological disorders</title>
      <p>By activation of its receptors, adenosine regulates many pathophysiological processes, particularly in excitable tissues of the brain (Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>). Its widespread functions in the body include regulation of seizure susceptibility [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>], neuroprotection [<xref ref-type="bibr" rid="CR40">40</xref>], regulation of pain perception [<xref ref-type="bibr" rid="CR130">130</xref>], sleep induction [<xref ref-type="bibr" rid="CR131">131</xref>], and involvement in Parkinson&#x2019;s disease [<xref ref-type="bibr" rid="CR132">132</xref>]. There is increasing evidence that the functional interaction of A<sub>1</sub>Rs with other neuronal receptors may contribute to fine tuning in synaptic transmission, and A<sub>1</sub>R agonists may represent a useful therapeutic approach for the treatment of some neurological disorders by regulating homeostasis in transmitter systems. However, the use of A<sub>1</sub>R agonists has not proved clinically useful due to mainly cardiovascular side effects as well as low brain permeability. Pioneering experimental approaches have been evaluated using focal drug delivery in epilepsy models. One experimental study has used intraventricular implantation of an adenosine-releasing synthetic polymer [<xref ref-type="bibr" rid="CR128">128</xref>]. In a later study, Guttinger et al. [<xref ref-type="bibr" rid="CR133">133</xref>] used encapsulated C2C12 myoblasts that were engineered to release adenosine by disruption of their adenosine kinase gene [<xref ref-type="bibr" rid="CR133">133</xref>]. The local delivery of adenosine by implanted cells appears to be a promising strategy for the control not only for affecting seizure activity but also other neurodegenerative diseases with dysregulated synaptic neurotransmission.</p>
    </sec>
    <sec id="Sec14">
      <title>Concluding remarks</title>
      <p>As a consequence of its ubiquitous distribution and because of its linkage to the energy pool, adenosine has evolved as an important messenger in extracellular signaling. Modifications in extracellular adenosine levels with subsequent alterations in the activation of its receptors interferes with the action of other receptor systems. Figure&#xA0;<xref rid="Fig4" ref-type="fig">4</xref> summarizes possible interactions of A<sub>1</sub>Rs with metabotropic receptors, Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref> shows the interactions between A<sub>1</sub>Rs and ionotropic receptors as well as with K<sub>ATP</sub>, and Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref> shows the neurological disorders where A<sub>1</sub>R interactions may play a role.
<fig id="Fig3"><label>Fig.&#xA0;3</label><caption><p>Schematic representation of possible interactions of A<sub>1</sub>Rs with metabotropic receptors. Heteromerization between presynaptically located A<sub>1</sub>Rs and A<sub>2A</sub>Rs, D<sub>1</sub>Rs, and P2Y<sub>1</sub>Rs causes changes in influencing glutamate release by adenosine. Cross talk between A<sub>1</sub>Rs and P2Y<sub>1</sub>Rs contributes mainly to triggering fast attenuation of transmitter release, whereas ADP acts as a ligand on the heteromer. During elevated adenosine levels, A<sub>2A</sub>R signaling becomes dominant in the A<sub>1</sub>R/A<sub>2A</sub>R complex, providing enhancement of glutamate release. The A<sub>1</sub>R/D<sub>1</sub>R heteromer requires both adenosine and dopamine to be activated and inhibits transmitter release</p></caption><graphic position="anchor" xlink:href="11302_2007_9065_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig.&#xA0;4</label><caption><p>Schematic representation of possible interactions of A<sub>1</sub>Rs with ionotropic receptors contributing to the fine-tuning of neurotransmission. Adenosine acting via presynaptic A<sub>1</sub>Rs may attenuate the influx of Ca<sup>2+</sup> through voltage-dependent calcium channels and thus decrease the release of glutamate and GABA, which inhibits or facilitates the activation of postsynaptically located NMDA receptors, respectively. Adenosine acting through postsynaptic A<sub>1</sub>Rs may activate K<sub>ATP</sub>, which leads to hyperpolarization of postsynaptic neurons and inhibits directly the activity of NMDA and GABA<sub>A</sub> receptors</p></caption><graphic position="anchor" xlink:href="11302_2007_9065_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#xA0;5</label><caption><p>Neurological disorders where A<sub>1</sub>R interactions may play a role</p></caption><graphic position="anchor" xlink:href="11302_2007_9065_Fig5_HTML" id="MO5"/></fig></p>
      <p>There is evidence that various regulatory mechanisms exist as well as multiple mechanisms that act independently of each other on the same cell depending on the brain region and cell type. The overaction and redundancy principle ensures transmitter homeostasis under pathophysiological conditions in a special time window. The function of adenosine receptors in the regulation of the synaptic transmission is complex.</p>
      <p>The key receptor in regulation of the neuronal transmission may be the A<sub>2A</sub>R, whereas the interaction of the A<sub>1</sub>R with metabotropic and ionotropic receptors as well as with K<sub>ATP</sub> serves as fine-tuning to inhibit synaptic transmission, as mentioned by Sebastiao and Ribeiro [<xref ref-type="bibr" rid="CR80">80</xref>]. A<sub>1</sub>Rs may play a nonessential role in normal physiology as demonstrated in mice lacking the A<sub>1</sub>Rs [<xref ref-type="bibr" rid="CR134">134</xref>]. However, they play an important protective role under pathophysiological conditions especially during hypoxia. The activation initiates a fast inhibition of the glutamatergic neurotransmission and the receptor interactions may contribute to its maintenance or can support the A<sub>1</sub>R-mediated effects.</p>
      <p>Most of our knowledge on receptor-receptor interactions involving the A<sub>1</sub>R results from experiments on cell cultures, slice preparation or, to a lesser extent, from in vivo experiments where regulation can be studied in principle or new drug targets can be characterized. These findings may contribute to a better understanding of disturbances in transmitter homeostasis. As our understanding of the complexity of receptor signaling and interaction develops, we may well gain new perspectives in new drug development. The clinical relevance of the testing models has often been questioned, however. Discordance between studies on cells and animal and human studies may be due to bias or failure of models to mimic clinical disease to an adequate degree. There are new techniques such as neuroimaging, nanotechnology, siPCR, and new selective receptor ligands that will help to overcome some of these aspects in the near future.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgement</title>
      <p>The authors thank Dr. Annette G. Beck-Sickinger, University of Leipzig for the generous gift of the Y<sub>1</sub> receptor agonist [F7, P34]pNPY.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Takeda</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kadowaki</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Haga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takaesu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mitaku</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Identification of G protein-coupled receptor genes from the human genome sequence</article-title>
          <source>FEBS Lett</source>
          <year>2002</year>
          <volume>520</volume>
          <fpage>97</fpage>
          <lpage>101</lpage>
        </citation>
        <citation citation-type="display-unstructured">Takeda S, Kadowaki S, Haga T, Takaesu H, Mitaku S (2002) Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 520:97&#x2013;101 <pub-id pub-id-type="pmid">12044878</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brink</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Harvey</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Bodenstein</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Venter</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Oliver</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology</article-title>
          <source>Br J Clinical Pharmacol</source>
          <year>2004</year>
          <volume>57</volume>
          <fpage>373</fpage>
          <lpage>387</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brink CB, Harvey BH, Bodenstein J, Venter DP, Oliver DW (2004) Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology. Br J Clinical Pharmacol 57:373&#x2013;387 <pub-id pub-id-type="pmid">15025734</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Mallol</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ferrada</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Cortes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Canela</surname>
              <given-names>EI</given-names>
            </name>
          </person-group>
          <article-title>The two-state dimer receptor model: a general model for receptor dimers</article-title>
          <source>Mol Pharmacol</source>
          <year>2006</year>
          <volume>69</volume>
          <fpage>1905</fpage>
          <lpage>1912</lpage>
        </citation>
        <citation citation-type="display-unstructured">Franco R, Casado V, Mallol J, Ferrada C, Ferre S, Fuxe K, Cortes A, Ciruela F, Lluis C, Canela EI (2006) The two-state dimer receptor model: a general model for receptor dimers. Mol Pharmacol 69:1905&#x2013;1912 <pub-id pub-id-type="pmid">16501032</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maudsley</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Luttrell</surname>
              <given-names>LM</given-names>
            </name>
          </person-group>
          <article-title>The origins of diversity and specificity in G protein-coupled receptor signaling</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2005</year>
          <volume>314</volume>
          <fpage>485</fpage>
          <lpage>494</lpage>
        </citation>
        <citation citation-type="display-unstructured">Maudsley S, Martin B, Luttrell LM (2005) The origins of diversity and specificity in G protein-coupled receptor signaling. J Pharmacol Exp Ther 314:485&#x2013;494 <pub-id pub-id-type="pmid">15805429</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agnati</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Benfenati</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Zini</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Hokfelt</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites</article-title>
          <source>Acta Physiol Scand</source>
          <year>1983</year>
          <volume>117</volume>
          <fpage>299</fpage>
          <lpage>301</lpage>
        </citation>
        <citation citation-type="display-unstructured">Agnati LF, Fuxe K, Benfenati F, Zini I, Hokfelt T (1983) On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites. Acta Physiol Scand 117:299&#x2013;301 <pub-id pub-id-type="pmid">6191525</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Agnati</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons</article-title>
          <source>Pharmacol Rev</source>
          <year>2003</year>
          <volume>55</volume>
          <fpage>509</fpage>
          <lpage>550</lpage>
        </citation>
        <citation citation-type="display-unstructured">Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55:509&#x2013;550 <pub-id pub-id-type="pmid">12869660</pub-id></citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Adenosine in the central nervous system: release mechanisms and extracellular concentrations</article-title>
          <source>J Neurochem</source>
          <year>2001</year>
          <volume>79</volume>
          <fpage>463</fpage>
          <lpage>484</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463&#x2013;484 <pub-id pub-id-type="pmid">11701750</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Mendonca</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Participation of adenosine receptors in neuroprotection</article-title>
          <source>Drug News Perspect</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>80</fpage>
          <lpage>86</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ribeiro JA, Sebastiao AM, de Mendonca A (2003) Participation of adenosine receptors in neuroprotection. Drug News Perspect 16:80&#x2013;86 <pub-id pub-id-type="pmid">12792668</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines</article-title>
          <source>Br J Pharmacol</source>
          <year>1990</year>
          <volume>1001</volume>
          <fpage>453</fpage>
          <lpage>459</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sebastiao AM, Stone TW, Ribeiro JA (1990) The inhibitory adenosine receptor at the neuromuscular junction and hippocampus of the rat: antagonism by 1,3,8-substituted xanthines. Br J Pharmacol 101:453&#x2013;459 <pub-id pub-id-type="pmid">2257444</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendonca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Almeida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bashir</surname>
              <given-names>ZI</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Endogenous adenosine attenuates long-term depression and depotentiation in the CA1 region of the rat hippocampus</article-title>
          <source>Neuropharmacology</source>
          <year>1997</year>
          <volume>36</volume>
          <fpage>161</fpage>
          <lpage>167</lpage>
        </citation>
        <citation citation-type="display-unstructured">De Mendonca A, Almeida T, Bashir ZI, Ribeiro JA (1997) Endogenous adenosine attenuates long-term depression and depotentiation in the CA1 region of the rat hippocampus. Neuropharmacology 36:161&#x2013;167 <pub-id pub-id-type="pmid">9144653</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendonca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Long-term potentiation observed upon blockade of adenosine A(1) receptors in rat hippocampus is N-methyl-D-aspartate receptor-dependent</article-title>
          <source>Neurosci Lett</source>
          <year>2000</year>
          <volume>291</volume>
          <fpage>81</fpage>
          <lpage>84</lpage>
        </citation>
        <citation citation-type="display-unstructured">De Mendonca A, Ribeiro JA (2000) Long-term potentiation observed upon blockade of adenosine A(1) receptors in rat hippocampus is N-methyl-D-aspartate receptor-dependent. Neurosci Lett 291:81&#x2013;84 <pub-id pub-id-type="pmid">10978579</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacoby</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bouhelal</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gerspacher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Seuwen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>The 7 TM G-protein-coupled receptor target family</article-title>
          <source>Chem Med Chem</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>761</fpage>
          <lpage>782</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jacoby E, Bouhelal R, Gerspacher M, Seuwen K (2006) The 7 TM G-protein-coupled receptor target family. Chem Med Chem 1:761&#x2013;782 <pub-id pub-id-type="pmid">16902930</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kostenis</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways</article-title>
          <source>Curr Pharm Design</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>1703</fpage>
          <lpage>1715</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kostenis E (2006) G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways. Curr Pharm Design 12:1703&#x2013;1715 </citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Klotz</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gebicke-Harter</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Calker</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>4956</fpage>
          <lpage>4964</lpage>
        </citation>
        <citation citation-type="display-unstructured">Biber K, Klotz KN, Berger M, Gebicke-Harter PJ, van Calker D (1997) Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J Neurosci 17:4956&#x2013;4964 <pub-id pub-id-type="pmid">9185533</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Basheer</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Arrigoni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Thatte</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Ambudkar</surname>
              <given-names>IS</given-names>
            </name>
            <name>
              <surname>McCarley</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Adenosine induces inositol 1,4,5-triphosphate receptor-mediated mobilization of intracellular calcium stores in basal forebrain cholinergic neurons</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>7680</fpage>
          <lpage>7686</lpage>
        </citation>
        <citation citation-type="display-unstructured">Basheer R, Arrigoni E, Thatte HS, Greene RW, Ambudkar IS, McCarley RW (2002) Adenosine induces inositol 1,4,5-triphosphate receptor-mediated mobilization of intracellular calcium stores in basal forebrain cholinergic neurons. J Neurosci 22:7680&#x2014;7686 <pub-id pub-id-type="pmid">12196591</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cortes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Heterodimeric adenosine receptors: a device to regulate neurotransmitter release</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2006</year>
          <volume>63</volume>
          <fpage>2427</fpage>
          <lpage>2431</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ciruela F, Ferre S, Casado V, Cortes A, Cunha RA, Lluis C, Franco R (2006) Heterodimeric adenosine receptors: a device to regulate neurotransmitter release. Cell Mol Life Sci 63:2427&#x2014;2431 <pub-id pub-id-type="pmid">17058035</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Lujan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Burgueno</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Canals</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Borycz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rebola</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Mallol</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Cortes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Canela</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Lopez-Gimenez</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Milligan</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1&#x2013;A2A receptor heteromers</article-title>
          <source>J Neurosci</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>2080</fpage>
          <lpage>2087</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080&#x2013;2087 <pub-id pub-id-type="pmid">16481441</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="other">Ferre S, Agnati LF, Ciruela F, Lluis C, Woods AS, Fuxe K, Franco R. Neurotransmitter receptor heteromers an their integrative role in &#x2018;local modules&#x2019;: the striatal spine module. Brain Res Rev 2007 (in press)</citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fragata</surname>
              <given-names>IR</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Nitric oxide mediates interactions between GABA(A) receptors and adenosine A(1) receptors in the rat hippocampus</article-title>
          <source>Eur J Pharmacol</source>
          <year>2006</year>
          <volume>543</volume>
          <fpage>32</fpage>
          <lpage>39</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fragata IR, Ribeiro JA, Sebastiao AM (2006) Nitric oxide mediates interactions between GABA(A) receptors and adenosine A(1) receptors in the rat hippocampus. Eur J Pharmacol 543:32&#x2013;39 <pub-id pub-id-type="pmid">16831416</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cortes</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Canela</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Mallol</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Agnati</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Partners for adenosine A1 receptors</article-title>
          <source>J Mol Neurosci</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>221</fpage>
          <lpage>232</lpage>
        </citation>
        <citation citation-type="display-unstructured">Franco R, Ciruela F, Casado V, Cortes A, Canela EI, Mallol J, Agnati LF, Ferre S, Fuxe K, Lluis C (2005) Partners for adenosine A1 receptors. J Mol Neurosci 26:221&#x2013;232 <pub-id pub-id-type="pmid">16012195</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhou</surname>
              <given-names>QY</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Olah</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Stiles</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Civelli</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>1992</year>
          <volume>89</volume>
          <fpage>7432</fpage>
          <lpage>7436</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhou QY, Li C, Olah ME, Johnson RA, Stiles GL, Civelli O (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA 89:7432&#x2013;7436 <pub-id pub-id-type="pmid">1323836</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Popik</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Carter</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A3 receptor stimulation and cerebral ischemia</article-title>
          <source>Eur J Pharmacol</source>
          <year>1994</year>
          <volume>263</volume>
          <fpage>59</fpage>
          <lpage>67</lpage>
        </citation>
        <citation citation-type="display-unstructured">Von Lubitz DK, Lin RC, Popik P, Carter MF, Jacobson KA (1994) Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59&#x2013;67 <pub-id pub-id-type="pmid">7821362</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Ye</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>McClellan</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both?</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1999</year>
          <volume>890</volume>
          <fpage>93</fpage>
          <lpage>106</lpage>
        </citation>
        <citation citation-type="display-unstructured">Von Lubitz DK, Ye W, McClellan J, Lin RC (1999) Stimulation of adenosine A3 receptors in cerebral ischemia. Neuronal death, recovery, or both? Ann N Y Acad Sci 890:93&#x2013;106 <pub-id pub-id-type="pmid">10668416</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DKJE</given-names>
            </name>
          </person-group>
          <article-title>Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?</article-title>
          <source>Eur J Pharmacol</source>
          <year>1999</year>
          <volume>365</volume>
          <fpage>9</fpage>
          <lpage>25</lpage>
        </citation>
        <citation citation-type="display-unstructured">Von Lubitz DKJE (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur J Pharmacol 365:9&#x2013;25 <pub-id pub-id-type="pmid">9988118</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lubitz</surname>
              <given-names>DKJE</given-names>
            </name>
          </person-group>
          <article-title>Adenosine in the treatment of stroke: yes, maybe, or absolutely not?</article-title>
          <source>Expert Opin Invest Drugs</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>619</fpage>
          <lpage>632</lpage>
        </citation>
        <citation citation-type="display-unstructured">Von Lubitz DKJE (2001) Adenosine in the treatment of stroke: yes, maybe, or absolutely not? Expert Opin Invest Drugs 10:619&#x2013;632 </citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rubaj</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zgodzinski</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sieklucka-Dziuba</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment</article-title>
          <source>Behav Brain Res</source>
          <year>2003</year>
          <volume>141</volume>
          <fpage>11</fpage>
          <lpage>17</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rubaj A, Zgodzinski W, Sieklucka-Dziuba M (2003) The influence of adenosine A3 receptor agonist: IB-MECA, on scopolamine- and MK-801-induced memory impairment. Behav Brain Res 141:11&#x2013;17 <pub-id pub-id-type="pmid">12672554</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sei</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>AMP</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A<sub>3</sub> receptor agonist-induced neurotoxicity in rat cerebellar granule neurons</article-title>
          <source>Drug Dev Res</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>267</fpage>
          <lpage>273</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sei Y, von Lubitz DK, AMP, Ji X, Jacobson KA (2006) Adenosine A3 receptor agonist-induced neurotoxicity in rat cerebellar granule neurons. Drug Dev Res 40:267&#x2013;273 </citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors</article-title>
          <source>Br J Pharmacol</source>
          <year>2003</year>
          <volume>140</volume>
          <fpage>305</fpage>
          <lpage>314</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pugliese AM, Latini S, Corradetti R, Pedata F (2003) Brief, repeated, oxygen-glucose deprivation episodes protect neurotransmission from a longer ischemic episode in the in vitro hippocampus: role of adenosine receptors. Br J Pharmacol 140:305&#x2013;314 <pub-id pub-id-type="pmid">12970092</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Coppi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Spalluto</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro</article-title>
          <source>Br J Pharmacol</source>
          <year>2006</year>
          <volume>147</volume>
          <fpage>524</fpage>
          <lpage>532</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pugliese AM, Coppi E, Spalluto G, Corradetti R, Pedata F (2006) A3 adenosine receptor antagonists delay irreversible synaptic failure caused by oxygen and glucose deprivation in the rat CA1 hippocampus in vitro. Br J Pharmacol 147:524&#x2013;532 <pub-id pub-id-type="pmid">16415905</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramkumar</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Stiles</surname>
              <given-names>GL</given-names>
            </name>
            <name>
              <surname>Beaven</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ali</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The A(3) adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells</article-title>
          <source>J Biol Chem</source>
          <year>1993</year>
          <volume>268</volume>
          <fpage>16887</fpage>
          <lpage>16890</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ramkumar V, Stiles GL, Beaven MA, Ali H (1993) The A(3) adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887&#x2013;16890 <pub-id pub-id-type="pmid">8349579</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbracchio</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ceruti</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Lubitz</surname>
              <given-names>DK</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Cattabeni</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain</article-title>
          <source>Mol Pharmacol</source>
          <year>1995</year>
          <volume>48</volume>
          <fpage>1038</fpage>
          <lpage>1045</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abbracchio MP, Brambilla R, Ceruti S, Kim HO, von Lubitz DK, Jacobson KA, Cattabeni F (1995) G protein-dependent activation of phospholipase C by adenosine A3 receptors in rat brain. Mol Pharmacol 48:1038&#x2013;1045 <pub-id pub-id-type="pmid">8848003</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gessi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Varani</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Merighi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cattabriga</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Iannotta</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Baraldi</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Borea</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study</article-title>
          <source>Mol Pharmacol</source>
          <year>2002</year>
          <volume>61</volume>
          <fpage>415</fpage>
          <lpage>424</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gessi S, Varani K, Merighi S, Cattabriga E, Iannotta V, Leung E, Baraldi PG, Borea PA (2002) A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study. Mol Pharmacol 61:415&#x2013;424 <pub-id pub-id-type="pmid">11809867</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kohno</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ji</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Mawhorter</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Koshiba</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium</article-title>
          <source>Blood</source>
          <year>1996</year>
          <volume>88</volume>
          <fpage>3569</fpage>
          <lpage>3574</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kohno Y, Ji X, Mawhorter SD, Koshiba M, Jacobson KA (1996) Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 88:3569&#x2013;3574 <pub-id pub-id-type="pmid">8896425</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Diao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HO</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>KA</given-names>
            </name>
          </person-group>
          <article-title>Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus</article-title>
          <source>J Neurosci</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>607</fpage>
          <lpage>614</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA (1997) Activation of hippocampal adenosine A3 receptors produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci 17:607&#x2013;614 <pub-id pub-id-type="pmid">8987783</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brand</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vissiennon</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Eschke</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons</article-title>
          <source>Neuropharmacology</source>
          <year>2000</year>
          <volume>40</volume>
          <fpage>85</fpage>
          <lpage>95</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brand A, Vissiennon Z, Eschke D, Nieber K (2000) Adenosine A(1) and A(3) receptors mediate inhibition of synaptic transmission in rat cortical neurons. Neuropharmacology 40:85&#x2013;95 <pub-id pub-id-type="pmid">11077074</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hentschel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lewerenz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons</article-title>
          <source>Restor Neurol Neurosci</source>
          <year>2003</year>
          <volume>21</volume>
          <fpage>55</fpage>
          <lpage>63</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hentschel S, Lewerenz A, Nieber K (2003) Activation of A(3) receptors by endogenous adenosine inhibits synaptic transmission during hypoxia in rat cortical neurons. Restor Neurol Neurosci 21:55&#x2013;63 <pub-id pub-id-type="pmid">12808203</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Rebola</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Costenla</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Halldner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A(3) receptors in the rat hippocampus: lack of interaction with A(1) receptors</article-title>
          <source>Drug Dev Res</source>
          <year>2003</year>
          <volume>58</volume>
          <fpage>428</fpage>
          <lpage>438</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lopes LV, Rebola N, Costenla AR, Halldner L, Jacobson MA, Oliveira CR, Richardson PJ, Fredholm BB, Ribeiro JA, Cunha RA (2003) Adenosine A(3) receptors in the rat hippocampus: lack of interaction with A(1) receptors. Drug Dev Res 58:428&#x2013;438 </citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Svenningsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Vaugeois</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Adenosine and brain function</article-title>
          <source>Int Rev Neurobiol</source>
          <year>2005</year>
          <volume>63</volume>
          <fpage>191</fpage>
          <lpage>270</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fredholm BB, Chen JF, Cunha RA, Svenningsson P, Vaugeois JM (2005) Adenosine and brain function. Int Rev Neurobiol 63:191&#x2013;270 <pub-id pub-id-type="pmid">15797469</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rebola</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Rodrigues</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Lopes</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus 1</article-title>
          <source>Neuroscience</source>
          <year>2005</year>
          <volume>133</volume>
          <fpage>79</fpage>
          <lpage>83</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rebola N, Rodrigues RJ, Lopes LV, Richardson PJ, Oliveira CR, Cunha RA (2005) Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus 1. Neuroscience 133:79&#x2013;83 <pub-id pub-id-type="pmid">15893632</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotection by adenosine in the brain: from A<sub>1</sub> receptor activation to A2A receptor blockade</article-title>
          <source>Purinergic Signalling</source>
          <year>2005</year>
          <volume>1</volume>
          <fpage>111</fpage>
          <lpage>134</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA (2005) Neuroprotection by adenosine in the brain: from A1 receptor activation to A2A receptor blockade. Purinergic Signalling 1:111&#x2013;134 </citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Betto</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reggio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Riccaiarello</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats</article-title>
          <source>Eur J Pharmacol</source>
          <year>1995</year>
          <volume>287</volume>
          <fpage>215</fpage>
          <lpage>217</lpage>
        </citation>
        <citation citation-type="display-unstructured">Popoli P, Betto P, Reggio R, Riccaiarello G (1995) Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats. Eur J Pharmacol 287:215&#x2013;217 <pub-id pub-id-type="pmid">8749040</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Corsi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Melani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Biachi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats</article-title>
          <source>Neuroreport</source>
          <year>2000</year>
          <volume>11</volume>
          <fpage>2591</fpage>
          <lpage>2595</lpage>
        </citation>
        <citation citation-type="display-unstructured">Corsi C, Melani A, Biachi L, Pedata F (2000) Striatal A2A adenosine receptor antagonism differentially modifies striatal glutamate outflow in vivo in young and aged rats. Neuroreport 11:2591&#x2013;2595 <pub-id pub-id-type="pmid">10943728</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Schwarzschild</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Caffeine&#x2019;s neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice</article-title>
          <source>Neurosci Lett</source>
          <year>2002</year>
          <volume>322</volume>
          <fpage>13</fpage>
          <lpage>16</lpage>
        </citation>
        <citation citation-type="display-unstructured">Xu K, Xu YH, Chen JF, Schwarzschild MA (2002) Caffeine&#x2019;s neuroprotection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity shows no tolerance to chronic caffeine administration in mice. Neurosci Lett 322:13&#x2013;16 <pub-id pub-id-type="pmid">11958832</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Reggio</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pezzola</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Effects of SCH 58261, an adenosine A2A receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake</article-title>
          <source>Neuropsychopharmacology</source>
          <year>2000</year>
          <volume>22</volume>
          <fpage>522</fpage>
          <lpage>529</lpage>
        </citation>
        <citation citation-type="display-unstructured">Popoli P, Reggio R, Pezzola A (2000) Effects of SCH 58261, an adenosine A2A receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake. Neuropsychopharmacology 22:522&#x2013;529 <pub-id pub-id-type="pmid">10731627</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dixon</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Widdowson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>PJ</given-names>
            </name>
          </person-group>
          <article-title>Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum</article-title>
          <source>J Neurochem</source>
          <year>1997</year>
          <volume>69</volume>
          <fpage>315</fpage>
          <lpage>321</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dixon AK, Widdowson L, Richardson PJ (1997) Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J Neurochem 69:315&#x2013;321 <pub-id pub-id-type="pmid">9202325</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats</article-title>
          <source>J Neurophysiol</source>
          <year>1999</year>
          <volume>82</volume>
          <fpage>3196</fpage>
          <lpage>3203</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196&#x2013;3203 <pub-id pub-id-type="pmid">10601453</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopes</surname>
              <given-names>LV</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Kull</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>112</volume>
          <fpage>319</fpage>
          <lpage>329</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA (2002) Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112:319&#x2013;329 <pub-id pub-id-type="pmid">12044450</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quarta</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Borycz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Solinas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Patkar</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hockemeyer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Woods</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Goldberg</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation</article-title>
          <source>J Neurochem</source>
          <year>2004</year>
          <volume>91</volume>
          <fpage>873</fpage>
          <lpage>880</lpage>
        </citation>
        <citation citation-type="display-unstructured">Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferre S (2004) Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. J Neurochem 91:873&#x2013;880 <pub-id pub-id-type="pmid">15525341</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bordoni</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Corradetti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Pepeu</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices</article-title>
          <source>Br J Pharmacol</source>
          <year>1999</year>
          <volume>128</volume>
          <fpage>1035</fpage>
          <lpage>1044</lpage>
        </citation>
        <citation citation-type="display-unstructured">Latini S, Bordoni F, Corradetti R, Pepeu G, Pedata F (1999) Effect of A2A adenosine receptor stimulation and antagonism on synaptic depression induced by in vitro ischaemia in rat hippocampal slices. Br J Pharmacol 128:1035&#x2013;1044 <pub-id pub-id-type="pmid">10556941</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gines</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hillion</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Torvinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Crom</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Canela</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Rondin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lew</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zoli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agnati</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Vernier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Dopamine D-1 and adenosine A(1) receptors form functionally interacting heteromeric complexes</article-title>
          <source>Proc Natl Acad Sci</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>8606</fpage>
          <lpage>8611</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gines S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, Agnati LF, Vernier P, Lluis C, Ferre S, Fuxe K, Franco R (2000) Dopamine D-1 and adenosine A(1) receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci 97:8606&#x2013;8611 <pub-id pub-id-type="pmid">10890919</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gimenez-Llort</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Finnman</surname>
              <given-names>UB</given-names>
            </name>
            <name>
              <surname>Martinez</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Scotti de Carolis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors</article-title>
          <source>Neuroreport</source>
          <year>1994</year>
          <volume>6</volume>
          <fpage>73</fpage>
          <lpage>76</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferre S, Popoli P, Gimenez-Llort L, Finnman UB, Martinez E, Scotti de Carolis A, Fuxe K (1994) Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors. Neuroreport 6:73&#x2013;76 <pub-id pub-id-type="pmid">7703433</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mayfield</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Miller</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Simosky</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Zahniser</surname>
              <given-names>NR</given-names>
            </name>
          </person-group>
          <article-title>Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamine D1 receptor interaction in rat brain limbic regions but not basal ganglia</article-title>
          <source>Synapse</source>
          <year>1999</year>
          <volume>33</volume>
          <fpage>274</fpage>
          <lpage>281</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mayfield RD, Jones BA, Miller HA, Simosky JK, Larson GA, Zahniser NR (1999) Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamine D1 receptor interaction in rat brain limbic regions but not basal ganglia. Synapse 33:274&#x2013;281 <pub-id pub-id-type="pmid">10421708</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Floran</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Barajas</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Floran</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Erlij</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Aceves</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>115</volume>
          <fpage>743</fpage>
          <lpage>751</lpage>
        </citation>
        <citation citation-type="display-unstructured">Floran B, Barajas C, Floran L, Erlij D, Aceves J (2002) Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Neuroscience 115:743&#x2013;751 <pub-id pub-id-type="pmid">12435413</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Popoli</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gimenez-Llort</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rimondini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Muller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Stromberg</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ogren</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Adenosine/dopamine interaction: implications for the treatment of Parkinson&#x2019;s disease</article-title>
          <source>Parkinsonism Relat Disord</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>235</fpage>
          <lpage>241</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ferre S, Popoli P, Gimenez-Llort L, Rimondini R, Muller CE, Stromberg I, Ogren SO, Fuxe K (2001) Adenosine/dopamine interaction: implications for the treatment of Parkinson&#x2019;s disease. Parkinsonism Relat Disord 7:235&#x2013;241 <pub-id pub-id-type="pmid">11331192</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Savitt</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>VL</given-names>
            </name>
            <name>
              <surname>Dawson</surname>
              <given-names>TM</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of Parkinson disease: molecules to medicine</article-title>
          <source>J Clin Invest</source>
          <year>2006</year>
          <volume>116</volume>
          <fpage>1744</fpage>
          <lpage>1754</lpage>
        </citation>
        <citation citation-type="display-unstructured">Savitt JM, Dawson VL, Dawson TM (2006) Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 116:1744&#x2013;1754 <pub-id pub-id-type="pmid">16823471</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Migita</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Loewy</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Ramabhadran</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Krause</surname>
              <given-names>JE</given-names>
            </name>
            <name>
              <surname>Waters</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system</article-title>
          <source>Brain Res</source>
          <year>2001</year>
          <volume>889</volume>
          <fpage>23</fpage>
          <lpage>37</lpage>
        </citation>
        <citation citation-type="display-unstructured">Migita K, Loewy AD, Ramabhadran TV, Krause JE, Waters SM (2001) Immunohistochemical localization of the neuropeptide Y Y1 receptor in rat central nervous system. Brain Res 889:23&#x2013;37 <pub-id pub-id-type="pmid">11166683</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kopp</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>ZQ</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Pedrazzini</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kresse</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Hokfelt</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>111</volume>
          <fpage>443</fpage>
          <lpage>532</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kopp J, Xu ZQ, Zhang X, Pedrazzini T, Herzog H, Kresse A, Wong H, Walsh JH, Hokfelt T (2002) Expression of the neuropeptide Y Y1 receptor in the CNS of rat and of wild-type and Y1 receptor knock-out mice. Focus on immunohistochemical localization. Neuroscience 111:443&#x2013;532 <pub-id pub-id-type="pmid">12031341</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wolak</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>DeJoseph</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Cator</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Mokashi</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Brownfield</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Urban</surname>
              <given-names>JH</given-names>
            </name>
          </person-group>
          <article-title>Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry</article-title>
          <source>J Comp Neurol</source>
          <year>2003</year>
          <volume>464</volume>
          <fpage>285</fpage>
          <lpage>311</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wolak ML, DeJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH (2003) Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464:285&#x2013;311 <pub-id pub-id-type="pmid">12900925</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bijak</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Neuropeptide Y reduces epileptiform discharges and excitatory synaptic transmission in rat frontal cortex in vitro</article-title>
          <source>Neuroscience</source>
          <year>2000</year>
          <volume>96</volume>
          <fpage>487</fpage>
          <lpage>494</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bijak M (2000) Neuropeptide Y reduces epileptiform discharges and excitatory synaptic transmission in rat frontal cortex in vitro. Neuroscience 96:487&#x2013;494 <pub-id pub-id-type="pmid">10717429</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cabrele</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beck-Sickinger</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family</article-title>
          <source>J Pept Sci</source>
          <year>2000</year>
          <volume>6</volume>
          <fpage>97</fpage>
          <lpage>122</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cabrele C, Beck-Sickinger AG (2000) Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci 6:97&#x2013;122 <pub-id pub-id-type="pmid">10759209</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Parrado</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Diaz-Cabiale</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Garcia-Coronel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Agnati</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Covenas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Narvaez</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Region specific galanin receptor/neuropeptide YY1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption</article-title>
          <source>Neuropharmacology</source>
          <year>2007</year>
          <volume>52</volume>
          <fpage>684</fpage>
          <lpage>692</lpage>
        </citation>
        <citation citation-type="display-unstructured">Parrado C, Diaz-Cabiale Z, Garcia-Coronel M, Agnati LF, Covenas R, Fuxe K, Narvaez JA (2007) Region specific galanin receptor/neuropeptide YY1 receptor interactions in the tel- and diencephalon of the rat. Relevance for food consumption. Neuropharmacology 52:684&#x2013;692 <pub-id pub-id-type="pmid">17087983</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sichardt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Beck-Sickinger</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Modulation of synaptic transmission by adenosine A<sub>1</sub> and NPY receptors on rat cortical neurons</article-title>
          <source>Purinergic Signalling</source>
          <year>2006</year>
          <volume>2</volume>
          <fpage>258</fpage>
          <lpage>259</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sichardt K, Beck-Sickinger AG, Nieber K (2006) Modulation of synaptic transmission by adenosine A1 and NPY receptors on rat cortical neurons. Purinergic Signalling 2:258&#x2013;259 </citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Purine and pyrimidine receptors</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2007</year>
          <volume>64</volume>
          <fpage>1471</fpage>
          <lpage>1483</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64:1471&#x2013;1483 <pub-id pub-id-type="pmid">17375261</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hosoda</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains</article-title>
          <source>FEBS Lett</source>
          <year>2002</year>
          <volume>531</volume>
          <fpage>299</fpage>
          <lpage>303</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yoshioka K, Hosoda R, Kuroda Y, Nakata H (2002) Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett 531:299&#x2013;303 <pub-id pub-id-type="pmid">12417330</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ikeuchi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Nishizaki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Adenosine activates the K+ channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor in hippocampal neurons</article-title>
          <source>Eur J Pharmacol</source>
          <year>1996</year>
          <volume>304</volume>
          <fpage>191</fpage>
          <lpage>199</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ikeuchi Y, Nishizaki T, Mori M, Okada Y (1996) Adenosine activates the K+ channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor in hippocampal neurons. Eur J Pharmacol 304:191&#x2013;199 <pub-id pub-id-type="pmid">8813602</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Heteromeric association creates a P2Y-like adenosine receptor</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>7617</fpage>
          <lpage>7622</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yoshioka K, Saitoh O, Nakata H (2001) Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci USA 98:7617&#x2013;7622 <pub-id pub-id-type="pmid">11390975</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells</article-title>
          <source>FEBS Lett</source>
          <year>2002</year>
          <volume>523</volume>
          <fpage>147</fpage>
          <lpage>151</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yoshioka K, Saitoh O, Nakata H (2002) Agonist-promoted heteromeric oligomerization between adenosine A(1) and P2Y(1) receptors in living cells. FEBS Lett 523:147&#x2013;151 <pub-id pub-id-type="pmid">12123822</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Saitoh</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Hetero-oligomerization between adenosine A(1) and P2Y(1) receptors in living cells: formation of ATP-sensitive adenosine receptors</article-title>
          <source>Drug Dev Res</source>
          <year>2003</year>
          <volume>58</volume>
          <fpage>340</fpage>
          <lpage>349</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nakata H, Yoshioka K, Saitoh S (2003) Hetero-oligomerization between adenosine A(1) and P2Y(1) receptors in living cells: formation of ATP-sensitive adenosine receptors. Drug Dev Res 58:340&#x2013;349 </citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kamiya</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Purinergic-receptor oligomerization: implications for neural functions in the central nervous system</article-title>
          <source>Neurotox Res</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>291</fpage>
          <lpage>297</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nakata H, Yoshioka K, Kamiya T (2004) Purinergic-receptor oligomerization: implications for neural functions in the central nervous system. Neurotox Res 6:291&#x2013;297 <pub-id pub-id-type="pmid">15545012</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakata</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshioka</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kamiya</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Tsuga</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Oyanagi</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Functions of heteromeric association between adenosine and P2Y receptors</article-title>
          <source>J Mol Neurosci</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>233</fpage>
          <lpage>238</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nakata H, Yoshioka K, Kamiya T, Tsuga H, Oyanagi K (2005) Functions of heteromeric association between adenosine and P2Y receptors. J Mol Neurosci 26:233&#x2013;238 <pub-id pub-id-type="pmid">16012196</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Heuss</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gahwiler</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Gerber</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures</article-title>
          <source>J Physiol</source>
          <year>2001</year>
          <volume>535</volume>
          <fpage>115</fpage>
          <lpage>123</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mori M, Heuss C, Gahwiler BH, Gerber U (2001) Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J Physiol 535:115&#x2013;123 <pub-id pub-id-type="pmid">11507162</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Poelchen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat</article-title>
          <source>Br J Pharmacol</source>
          <year>1997</year>
          <volume>122</volume>
          <fpage>423</fpage>
          <lpage>430</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nieber K, Poelchen W, Illes P (1997) Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat. Br J Pharmacol 122:423&#x2013;430 <pub-id pub-id-type="pmid">9351497</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Poelchen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Sieler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Wirkner</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Co-transmitter function of ATP in central catecholaminergic neurons of the rat</article-title>
          <source>Neuroscience</source>
          <year>2001</year>
          <volume>102</volume>
          <fpage>593</fpage>
          <lpage>602</lpage>
        </citation>
        <citation citation-type="display-unstructured">Poelchen W, Sieler D, Wirkner K, Illes P (2001) Co-transmitter function of ATP in central catecholaminergic neurons of the rat. Neuroscience 102:593&#x2013;602 <pub-id pub-id-type="pmid">11226696</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halliwell</surname>
              <given-names>RF</given-names>
            </name>
          </person-group>
          <article-title>A short history of the rise of the molecular pharmacology of ionotropic drug receptors</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2007</year>
          <volume>28</volume>
          <fpage>214</fpage>
          <lpage>219</lpage>
        </citation>
        <citation citation-type="display-unstructured">Halliwell RF (2007) A short history of the rise of the molecular pharmacology of ionotropic drug receptors. Trends Pharmacol Sci 28:214&#x2013;219 <pub-id pub-id-type="pmid">17416425</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romanelli</surname>
              <given-names>MN</given-names>
            </name>
            <name>
              <surname>Gratteri</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Guandalini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Martini</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Bonaccini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gualtieri</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Central nicotinic receptors: structure, function, ligands, and therapeutic potential</article-title>
          <source>Chem Med Chem</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>746</fpage>
          <lpage>767</lpage>
        </citation>
        <citation citation-type="display-unstructured">Romanelli MN, Gratteri P, Guandalini L, Martini E, Bonaccini C, Gualtieri F (2007) Central nicotinic receptors: structure, function, ligands, and therapeutic potential. Chem Med Chem 2:746&#x2013;767 <pub-id pub-id-type="pmid">17295372</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boehm</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kubista</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors</article-title>
          <source>Pharmacol Rev</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>43</fpage>
          <lpage>99</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boehm S, Kubista H (2002) Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54:43&#x2013;99 <pub-id pub-id-type="pmid">11870260</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gundlfinger</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bischofberger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Johenning</surname>
              <given-names>FW</given-names>
            </name>
            <name>
              <surname>Torvinen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Schmitz</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Breustedt</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels</article-title>
          <source>J Physiol</source>
          <year>2007</year>
          <volume>582</volume>
          <issue>Pt 1</issue>
          <fpage>263</fpage>
          <lpage>277</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gundlfinger A, Bischofberger J, Johenning FW, Torvinen M, Schmitz D, Breustedt J (2007) Adenosine modulates transmission at the hippocampal mossy fibre synapse via direct inhibition of presynaptic calcium channels. J Physiol 582(Pt 1):263&#x2013;277 <pub-id pub-id-type="pmid">17478533</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Masino</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>The role and regulation of adenosine in the central nervous system</article-title>
          <source>Annu Rev Neurosci</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>31</fpage>
          <lpage>55</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31&#x2013;55 <pub-id pub-id-type="pmid">11283304</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbracchio</surname>
              <given-names>MP</given-names>
            </name>
            <name>
              <surname>Cattabeni</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>1999</year>
          <volume>890</volume>
          <fpage>79</fpage>
          <lpage>92</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abbracchio MP, Cattabeni F (1999) Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases. Ann N Y Acad Sci 890:79&#x2013;92 <pub-id pub-id-type="pmid">10668415</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Fine-tuning neuromodulation by adenosine</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>341</fpage>
          <lpage>346</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sebastiao AM, Ribeiro JA (2000) Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21:341&#x2013;346 <pub-id pub-id-type="pmid">10973087</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Henry</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Adenosine receptor blockade reveals N-methyl-D-aspartate receptor- and voltage-sensitive dendritic spikes in rat hippocampal CA1 pyramidal cells in vitro</article-title>
          <source>Neuroscience</source>
          <year>2000</year>
          <volume>100</volume>
          <fpage>21</fpage>
          <lpage>31</lpage>
        </citation>
        <citation citation-type="display-unstructured">Li H, Henry JL (2000) Adenosine receptor blockade reveals N-methyl-D-aspartate receptor- and voltage-sensitive dendritic spikes in rat hippocampal CA1 pyramidal cells in vitro. Neuroscience 100:21&#x2013;31 <pub-id pub-id-type="pmid">10996455</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nikbakht</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Suppression of presynaptic responses to adenosine by activation of NMDA receptors</article-title>
          <source>Eur J Pharmacol</source>
          <year>2001</year>
          <volume>427</volume>
          <fpage>13</fpage>
          <lpage>25</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nikbakht MR, Stone TW (2001) Suppression of presynaptic responses to adenosine by activation of NMDA receptors. Eur J Pharmacol 427:13&#x2013;25 <pub-id pub-id-type="pmid">11553359</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boeck</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Kroth</surname>
              <given-names>EH</given-names>
            </name>
            <name>
              <surname>Bronzatto</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Vendite</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity</article-title>
          <source>Neuropharmacology</source>
          <year>2005</year>
          <volume>49</volume>
          <fpage>17</fpage>
          <lpage>24</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boeck CR, Kroth EH, Bronzatto MJ, Vendite D (2005) Adenosine receptors co-operate with NMDA preconditioning to protect cerebellar granule cells against glutamate neurotoxicity. Neuropharmacology 49:17&#x2013;24 <pub-id pub-id-type="pmid">15992577</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schotanus</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Chergui</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A(1) receptors: evidence from knockout mice</article-title>
          <source>Neuropharmacology</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>272</fpage>
          <lpage>282</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schotanus SM, Fredholm BB, Chergui K (2006) NMDA depresses glutamatergic synaptic transmission in the striatum through the activation of adenosine A(1) receptors: evidence from knockout mice. Neuropharmacology 51:272&#x2013;282 <pub-id pub-id-type="pmid">16712880</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heinbockel</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Pape</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Modulatory effects of adenosine on inhibitory postsynaptic potentials in the lateral amygdala of the rat</article-title>
          <source>Br J Pharmacol</source>
          <year>1999</year>
          <volume>128</volume>
          <fpage>190</fpage>
          <lpage>196</lpage>
        </citation>
        <citation citation-type="display-unstructured">Heinbockel T, Pape HC (1999) Modulatory effects of adenosine on inhibitory postsynaptic potentials in the lateral amygdala of the rat. Br J Pharmacol 128:190&#x2013;196 <pub-id pub-id-type="pmid">10498851</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shen</surname>
              <given-names>KZ</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>SW</given-names>
            </name>
          </person-group>
          <article-title>Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones</article-title>
          <source>J Physiol</source>
          <year>1997</year>
          <volume>505</volume>
          <issue>Pt 1</issue>
          <fpage>153</fpage>
          <lpage>163</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shen KZ, Johnson SW (1997) Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones. J Physiol 505(Pt 1):153&#x2013;163 <pub-id pub-id-type="pmid">9409479</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ulrich</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Huguenard</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity</article-title>
          <source>Neuron</source>
          <year>1995</year>
          <volume>15</volume>
          <fpage>909</fpage>
          <lpage>918</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ulrich D, Huguenard JR (1995) Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity. Neuron 15:909&#x2013;918 <pub-id pub-id-type="pmid">7576639</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Pol</surname>
              <given-names>AN</given-names>
            </name>
          </person-group>
          <article-title>Adenosine modulation of calcium currents and presynaptic inhibition of GABA release in suprachiasmatic and arcuate nucleus neurons</article-title>
          <source>J Neurophysiol</source>
          <year>1997</year>
          <volume>77</volume>
          <fpage>3035</fpage>
          <lpage>3047</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen G, van den Pol AN (1997) Adenosine modulation of calcium currents and presynaptic inhibition of GABA release in suprachiasmatic and arcuate nucleus neurons. J Neurophysiol 77:3035&#x2013;3047 <pub-id pub-id-type="pmid">9212255</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neary</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Dash</surname>
              <given-names>PK</given-names>
            </name>
          </person-group>
          <article-title>Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors</article-title>
          <source>Neuroreport</source>
          <year>1996</year>
          <volume>7</volume>
          <fpage>2893</fpage>
          <lpage>2896</lpage>
        </citation>
        <citation citation-type="display-unstructured">Neary JT, Zhu Q, Kang Y, Dash PK (1996) Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors. Neuroreport 7:2893&#x2013;2896 <pub-id pub-id-type="pmid">9116204</pub-id></citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals</article-title>
          <source>Neurochem Res</source>
          <year>2001</year>
          <volume>26</volume>
          <fpage>979</fpage>
          <lpage>991</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA (2001) Regulation of the ecto-nucleotidase pathway in rat hippocampal nerve terminals. Neurochem Res 26:979&#x2013;991 <pub-id pub-id-type="pmid">11699950</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Molecular physiology of P2 receptors in the central nervous system</article-title>
          <source>Eur J Pharmacol</source>
          <year>2001</year>
          <volume>483</volume>
          <fpage>5</fpage>
          <lpage>17</lpage>
        </citation>
        <citation citation-type="display-unstructured">Illes P, Ribeiro JA (2001) Molecular physiology of P2 receptors in the central nervous system. Eur J Pharmacol 483:5&#x2013;17 <pub-id pub-id-type="pmid">14709321</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hebb</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex</article-title>
          <source>Eur J Pharmacol</source>
          <year>1998</year>
          <volume>344</volume>
          <fpage>121</fpage>
          <lpage>125</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hebb MO, White TD (1998) Co-administration of adenosine kinase and deaminase inhibitors produces supra-additive potentiation of N-methyl-D-aspartate-evoked adenosine formation in cortex. Eur J Pharmacol 344:121&#x2013;125 <pub-id pub-id-type="pmid">9600645</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Correia-de-Sa</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides</article-title>
          <source>Br J Pharmacol</source>
          <year>1996</year>
          <volume>119</volume>
          <fpage>253</fpage>
          <lpage>260</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Correia-de-Sa P, Sebastiao AM, Ribeiro JA (1996) Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br J Pharmacol 119:253&#x2013;260 <pub-id pub-id-type="pmid">8886406</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masino</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Diao</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zahniser</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Larson</surname>
              <given-names>GA</given-names>
            </name>
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors</article-title>
          <source>J Pharmacol Exp Ther</source>
          <year>2002</year>
          <volume>303</volume>
          <fpage>356</fpage>
          <lpage>363</lpage>
        </citation>
        <citation citation-type="display-unstructured">Masino SA, Diao L, Illes P, Zahniser NR, Larson GA, Johansson B, Fredholm BB, Dunwiddie TV (2002) Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors. J Pharmacol Exp Ther 303:356&#x2013;363 <pub-id pub-id-type="pmid">12235271</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendonca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation</article-title>
          <source>Neuroreport</source>
          <year>1995</year>
          <volume>6</volume>
          <fpage>1097</fpage>
          <lpage>1100</lpage>
        </citation>
        <citation citation-type="display-unstructured">De Mendonca A, Sebastiao AM, Ribeiro JA (1995) Inhibition of NMDA receptor-mediated currents in isolated rat hippocampal neurones by adenosine A1 receptor activation. Neuroreport 6:1097&#x2013;1100 <pub-id pub-id-type="pmid">7662885</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Costenla</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Mendonca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina</article-title>
          <source>Exp Eye Res</source>
          <year>1999</year>
          <volume>68</volume>
          <fpage>367</fpage>
          <lpage>370</lpage>
        </citation>
        <citation citation-type="display-unstructured">Costenla AR, de Mendonca A, Sebastiao A, Ribeiro JA (1999) An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina. Exp Eye Res 68:367&#x2013;370 <pub-id pub-id-type="pmid">10079145</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Hoffer</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1981</year>
          <volume>316</volume>
          <fpage>326</fpage>
          <lpage>330</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dunwiddie TV, Hoffer BJ, Fredholm BB (1981) Alkylxanthines elevate hippocampal excitability. Evidence for a role of endogenous adenosine. Naunyn Schmiedebergs Arch Pharmacol 316:326&#x2013;330 <pub-id pub-id-type="pmid">6267486</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Shindou</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ichimura</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nonaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kase</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The role of adenosine A2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons</article-title>
          <source>J Neurosci</source>
          <year>1996</year>
          <volume>16</volume>
          <fpage>605</fpage>
          <lpage>611</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mori A, Shindou T, Ichimura M, Nonaka H, Kase H (1996) The role of adenosine A2A receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons. J Neurosci 16:605&#x2013;611 <pub-id pub-id-type="pmid">8551344</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>YC</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>KS</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the mechanism underlying the reversal of long term potentiation by low frequency stimulation at hippocampal CA1 synapses</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>48108</fpage>
          <lpage>48117</lpage>
        </citation>
        <citation citation-type="display-unstructured">Huang CC, Liang YC, Hsu KS (2001) Characterization of the mechanism underlying the reversal of long term potentiation by low frequency stimulation at hippocampal CA1 synapses. J Biol Chem 276:48108&#x2013;48117 <pub-id pub-id-type="pmid">11679581</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Scammell</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Arrigoni</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Ronan</surname>
              <given-names>PJ</given-names>
            </name>
            <name>
              <surname>Saper</surname>
              <given-names>CB</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>RW</given-names>
            </name>
          </person-group>
          <article-title>Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector</article-title>
          <source>J Neurosci</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>5762</fpage>
          <lpage>5770</lpage>
        </citation>
        <citation citation-type="display-unstructured">Scammell TE, Arrigoni E, Thompson MA, Ronan PJ, Saper CB, Greene RW (2003) Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector. J Neurosci 23:5762&#x2013;5770 <pub-id pub-id-type="pmid">12843280</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wardas</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotective role of adenosine in the CNS</article-title>
          <source>Pol J Pharmacol</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>313</fpage>
          <lpage>326</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wardas J (2002) Neuroprotective role of adenosine in the CNS. Polh J Pharmacol 54:313&#x2013;326 <pub-id pub-id-type="pmid">12523485</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kittler</surname>
              <given-names>JT</given-names>
            </name>
            <name>
              <surname>Moss</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Modulation of GABA(A) receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition</article-title>
          <source>Curr Opin Neurobiol</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>341</fpage>
          <lpage>347</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kittler JT, Moss SJ (2003) Modulation of GABA(A) receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol 13:341&#x2013;347 <pub-id pub-id-type="pmid">12850219</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YQ</given-names>
            </name>
          </person-group>
          <article-title>Adenosine suppresses GABAA receptor&#x2013;mediated responses in rat sacral dorsal commissural neurons</article-title>
          <source>Auton Neurosci</source>
          <year>2004</year>
          <volume>111</volume>
          <fpage>71</fpage>
          <lpage>79</lpage>
        </citation>
        <citation citation-type="display-unstructured">Li H, Wu L, Li YQ (2004) Adenosine suppresses GABAA receptor&#x2013;mediated responses in rat sacral dorsal commissural neurons. Auton Neurosci 111:71&#x2013;79 <pub-id pub-id-type="pmid">15182736</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Akhondzadeh</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
          </person-group>
          <article-title>Interaction between adenosine and GABAA receptors on hippocampal neurones</article-title>
          <source>Brain Res</source>
          <year>1994</year>
          <volume>665</volume>
          <fpage>229</fpage>
          <lpage>236</lpage>
        </citation>
        <citation citation-type="display-unstructured">Akhondzadeh S, Stone TW (1994) Interaction between adenosine and GABAA receptors on hippocampal neurones. Brain Res 665:229&#x2013;236 <pub-id pub-id-type="pmid">7895058</pub-id></citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Madden</surname>
              <given-names>KP</given-names>
            </name>
          </person-group>
          <article-title>Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits</article-title>
          <source>Stroke</source>
          <year>1994</year>
          <volume>25</volume>
          <fpage>2271</fpage>
          <lpage>2274</lpage>
        </citation>
        <citation citation-type="display-unstructured">Madden KP (1994) Effect of gamma-aminobutyric acid modulation on neuronal ischemia in rabbits. Stroke 25:2271&#x2013;2274 <pub-id pub-id-type="pmid">7974555</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O&#x2019;Regan</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>RE</given-names>
            </name>
            <name>
              <surname>Perkins</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Phillis</surname>
              <given-names>JW</given-names>
            </name>
          </person-group>
          <article-title>Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex</article-title>
          <source>Brain Res</source>
          <year>1992</year>
          <volume>582</volume>
          <fpage>22</fpage>
          <lpage>26</lpage>
        </citation>
        <citation citation-type="display-unstructured">O&#x2019;Regan MH, Simpson RE, Perkins LM, Phillis JW (1992) Adenosine receptor agonists inhibit the release of gamma-aminobutyric acid (GABA) from the ischemic rat cerebral cortex. Brain Res 582:22&#x2013;26 <pub-id pub-id-type="pmid">1498681</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heron</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lekieffre</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Peillet</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Lasbennes</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Seylaz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Plotkine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Boulu</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia</article-title>
          <source>Brain Res</source>
          <year>1994</year>
          <volume>641</volume>
          <fpage>217</fpage>
          <lpage>224</lpage>
        </citation>
        <citation citation-type="display-unstructured">Heron A, Lekieffre D, Le Peillet E, Lasbennes F, Seylaz J, Plotkine M, Boulu RG (1994) Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia. Brain Res 641:217&#x2013;224 <pub-id pub-id-type="pmid">8012824</pub-id></citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lucchi</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Latini</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>deMendonca</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Adenosine by activating A(1) receptors prevents GABA(A)-mediated actions during hypoxia in the rat hippocampus</article-title>
          <source>Brain Res</source>
          <year>1996</year>
          <volume>732</volume>
          <fpage>261</fpage>
          <lpage>266</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lucchi R, Latini S, deMendonca A, Sebastiao AM, Ribeiro JA (1996) Adenosine by activating A(1) receptors prevents GABA(A)-mediated actions during hypoxia in the rat hippocampus. Brain Res 732:261&#x2013;266 <pub-id pub-id-type="pmid">8891295</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rufke</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Scheibner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Klotz</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>In vitro desensitization of adenosine A<sub>1</sub> receptors after exposure to adenosine analogues</article-title>
          <source>Arch Pharm</source>
          <year>2006</year>
          <volume>372</volume>
          <fpage>117/41</fpage>
        </citation>
        <citation citation-type="display-unstructured">Rufke C, Scheibner T, Klotz KN, Nieber K (2006) In vitro desensitization of adenosine A1 receptors after exposure to adenosine analogues. Arch Pharm 372:117/41 </citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wetherington</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lambert</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>1248</fpage>
          <lpage>1255</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wetherington JP, Lambert NA (2002) Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors. J Neurosci 22:1248&#x2013;1255 <pub-id pub-id-type="pmid">11850452</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dar</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Mouse cerebellar adenosine-glutamate interactions and modulation of ethanol-induced motor incoordination</article-title>
          <source>Alcohol Clin Exp Res</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>1395</fpage>
          <lpage>1403</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dar MS (2002) Mouse cerebellar adenosine-glutamate interactions and modulation of ethanol-induced motor incoordination. Alcohol Clin Exp Res 26:1395&#x2013;1403 <pub-id pub-id-type="pmid">12351935</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>North</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Molecular physiology of P2X receptors</article-title>
          <source>Physiol Rev</source>
          <year>2002</year>
          <volume>82</volume>
          <fpage>1013</fpage>
          <lpage>1067</lpage>
        </citation>
        <citation citation-type="display-unstructured">North RA (2002) Molecular physiology of P2X receptors. Physiol Rev 82:1013&#x2013;1067 <pub-id pub-id-type="pmid">12270951</pub-id></citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burnstock</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Physiology and pathophysiology of purinergic neurotransmission</article-title>
          <source>Physiol Rev</source>
          <year>2007</year>
          <volume>87</volume>
          <fpage>659</fpage>
          <lpage>797</lpage>
        </citation>
        <citation citation-type="display-unstructured">Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659&#x2013;797 <pub-id pub-id-type="pmid">17429044</pub-id></citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sneddon</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Westfall</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Todorov</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Mihaylova-Todorova</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Westfall</surname>
              <given-names>DP</given-names>
            </name>
            <name>
              <surname>Kennedy</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Modulation of purinergic neurotransmission</article-title>
          <source>Prog Brain Res</source>
          <year>1999</year>
          <volume>120</volume>
          <fpage>11</fpage>
          <lpage>20</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sneddon P, Westfall TD, Todorov LD, Mihaylova-Todorova S, Westfall DP, Kennedy C (1999) Modulation of purinergic neurotransmission. Prog Brain Res 120:11&#x2013;20 <pub-id pub-id-type="pmid">10550984</pub-id></citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Proctor</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
          </person-group>
          <article-title>Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus</article-title>
          <source>Brain Res</source>
          <year>1987</year>
          <volume>426</volume>
          <fpage>187</fpage>
          <lpage>190</lpage>
        </citation>
        <citation citation-type="display-unstructured">Proctor WR, Dunwiddie TV (1987) Pre- and postsynaptic actions of adenosine in the in vitro rat hippocampus. Brain Res 426:187&#x2013;190 <pub-id pub-id-type="pmid">2825915</pub-id></citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Vizi</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices</article-title>
          <source>J Neurochem</source>
          <year>1996</year>
          <volume>67</volume>
          <fpage>2180</fpage>
          <lpage>2187</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Vizi ES, Ribeiro JA, Sebastiao AM (1996) Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem 67:2180&#x2013;2187 <pub-id pub-id-type="pmid">8863529</pub-id></citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zimmermann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Extracellular metabolism of ATP and other nucleotides</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>2000</year>
          <volume>362</volume>
          <fpage>299</fpage>
          <lpage>309</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zimmermann H (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362:299&#x2013;309 <pub-id pub-id-type="pmid">11111825</pub-id></citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors</article-title>
          <source>J Neurosci</source>
          <year>1998</year>
          <volume>18</volume>
          <fpage>1987</fpage>
          <lpage>1995</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cunha RA, Sebastiao AM, Ribeiro JA (1998) Inhibition by ATP of hippocampal synaptic transmission requires localized extracellular catabolism by ecto-nucleotidases into adenosine and channeling to adenosine A1 receptors. J Neurosci 18:1987&#x2013;1995 <pub-id pub-id-type="pmid">9482785</pub-id></citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sebastiao</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Cascalheira</surname>
              <given-names>JF</given-names>
            </name>
            <name>
              <surname>Ribeiro</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases</article-title>
          <source>Prog Brain Res</source>
          <year>1999</year>
          <volume>120</volume>
          <fpage>183</fpage>
          <lpage>192</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sebastiao AM, Cunha RA, Cascalheira JF, Ribeiro JA (1999) Adenine nucleotides as inhibitors of synaptic transmission: role of localised ectonucleotidases. Prog Brain Res 120:183&#x2013;192 <pub-id pub-id-type="pmid">10550997</pub-id></citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coppi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Pugliese</surname>
              <given-names>AM</given-names>
            </name>
            <name>
              <surname>Stephan</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mueller</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Pedata</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices</article-title>
          <source>Purinergic Signalling</source>
          <year>2007</year>
          <volume>3</volume>
          <fpage>203</fpage>
          <lpage>219</lpage>
        </citation>
        <citation citation-type="display-unstructured">Coppi E, Pugliese AM, Stephan H, Mueller CE, Pedata F (2007) Role of P2 purinergic receptors in synaptic transmission under normoxic and ischaemic conditions in the CA1 region of rat hippocampal slices. Purinergic Signalling 3:203&#x2013;219 </citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazdunski</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>ATP-sensitive potassium channels: an overview</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>1994</year>
          <volume>24</volume>
          <issue>Suppl 4</issue>
          <fpage>S1</fpage>
          <lpage>S5</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lazdunski M (1994) ATP-sensitive potassium channels: an overview. J Cardiovasc Pharmacol 24(Suppl 4):S1&#x2013;S5 <pub-id pub-id-type="pmid">7898102</pub-id></citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pissarek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Garcia de Arriba</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sch&#xE4;fer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sieler</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Nieber</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Illes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Changes by short-term hypoxia in the membrane properties of pyramidal cells and the levels of purine and pyrimidine nucleotides in slices of rat neocortex; effects of agonists and antagonists of ATP-dependent potassium channels</article-title>
          <source>Naunyn Schmiedebergs Arch Pharmacol</source>
          <year>1998</year>
          <volume>358</volume>
          <fpage>430</fpage>
          <lpage>439</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pissarek M, Garcia de Arriba S, Sch&#xE4;fer M, Sieler D, Nieber K, Illes P (1998) Changes by short-term hypoxia in the membrane properties of pyramidal cells and the levels of purine and pyrimidine nucleotides in slices of rat neocortex; effects of agonists and antagonists of ATP-dependent potassium channels. Naunyn Schmiedebergs Arch Pharmacol 358:430&#x2013;439 <pub-id pub-id-type="pmid">9826065</pub-id></citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mironov</surname>
              <given-names>SL</given-names>
            </name>
            <name>
              <surname>Langohr</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>A1 adenosine receptors modulate respiratory activity of the neonatal mouse via the cAMP-mediated signaling pathway</article-title>
          <source>J Neurophysiol</source>
          <year>1999</year>
          <volume>81</volume>
          <fpage>247</fpage>
          <lpage>255</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mironov SL, Langohr K, Richter DW (1999) A1 adenosine receptors modulate respiratory activity of the neonatal mouse via the cAMP-mediated signaling pathway. J Neurophysiol 81:247&#x2013;255 <pub-id pub-id-type="pmid">9914285</pub-id></citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andoh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ishiwa</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kamiya</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Echigo</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>A1 adenosine receptor-mediated modulation of neuronal ATP-sensitive K channels in rat substantia nigra</article-title>
          <source>Brain Res</source>
          <year>2006</year>
          <volume>1124</volume>
          <fpage>55</fpage>
          <lpage>61</lpage>
        </citation>
        <citation citation-type="display-unstructured">Andoh T, Ishiwa D, Kamiya Y, Echigo N, Goto T, Yamada Y (2006) A1 adenosine receptor-mediated modulation of neuronal ATP-sensitive K channels in rat substantia nigra. Brain Res 1124:55&#x2013;61 <pub-id pub-id-type="pmid">17084818</pub-id></citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shan</surname>
              <given-names>HQ</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Effect of adenosine on adenosine triphosphate-sensitive potassium channel during hypoxia in rat hippocampal neurons</article-title>
          <source>Neurosci Lett</source>
          <year>2000</year>
          <volume>286</volume>
          <fpage>45</fpage>
          <lpage>48</lpage>
        </citation>
        <citation citation-type="display-unstructured">Shan HQ, Cheng JS (2000) Effect of adenosine on adenosine triphosphate-sensitive potassium channel during hypoxia in rat hippocampal neurons. Neurosci Lett 286:45&#x2013;48 <pub-id pub-id-type="pmid">10822149</pub-id></citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hu</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>YN</given-names>
            </name>
            <name>
              <surname>Jan</surname>
              <given-names>LY</given-names>
            </name>
          </person-group>
          <article-title>ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C</article-title>
          <source>Neuron</source>
          <year>2003</year>
          <volume>38</volume>
          <fpage>417</fpage>
          <lpage>432</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hu K, Huang CS, Jan YN, Jan LY (2003) ATP-sensitive potassium channel traffic regulation by adenosine and protein kinase C. Neuron 38:417&#x2013;432 <pub-id pub-id-type="pmid">12741989</pub-id></citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Svenningsson</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Moine</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Fisone</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Distribution, biochemistry and function of striatal adenosine A2A receptors</article-title>
          <source>Prog Neurobiol</source>
          <year>1999</year>
          <volume>59</volume>
          <fpage>355</fpage>
          <lpage>396</lpage>
        </citation>
        <citation citation-type="display-unstructured">Svenningsson P, Le Moine C, Fisone G, Fredholm BB (1999) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59:355&#x2013;396 <pub-id pub-id-type="pmid">10501634</pub-id></citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boison</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies</article-title>
          <source>Neuroscientist</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>25</fpage>
          <lpage>36</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boison D (2005) Adenosine and epilepsy: from therapeutic rationale to new therapeutic strategies. Neuroscientist 11:25&#x2013;36 <pub-id pub-id-type="pmid">15632276</pub-id></citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pagonopoulou</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Efthimiadou</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Asimakopoulos</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Nikolettos</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches</article-title>
          <source>Neurosci Res</source>
          <year>2006</year>
          <volume>56</volume>
          <fpage>14</fpage>
          <lpage>20</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pagonopoulou O, Efthimiadou A, Asimakopoulos B, Nikolettos NK (2006) Modulatory role of adenosine and its receptors in epilepsy: possible therapeutic approaches. Neurosci Res 56:14&#x2013;20 <pub-id pub-id-type="pmid">16846657</pub-id></citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sadigh-Lindell</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Sylven</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Berglund</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Eriksson</surname>
              <given-names>BE</given-names>
            </name>
          </person-group>
          <article-title>Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study</article-title>
          <source>J Cardiovasc Pharmacol</source>
          <year>2003</year>
          <volume>42</volume>
          <fpage>757</fpage>
          <lpage>763</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sadigh-Lindell B, Sylven C, Berglund M, Eriksson BE (2003) Role of adenosine and opioid-receptor mechanisms for pain in patients with silent myocardial ischemia or angina pectoris: a double-blind, placebo-controlled study. J Cardiovasc Pharmacol 42:757&#x2013;763 <pub-id pub-id-type="pmid">14639098</pub-id></citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Porkka-Heiskanen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Kalinchuk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Alanko</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Urrila</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stenberg</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Adenosine, energy metabolism, and sleep</article-title>
          <source>Sci World J</source>
          <year>2003</year>
          <volume>3</volume>
          <fpage>790</fpage>
          <lpage>798</lpage>
        </citation>
        <citation citation-type="display-unstructured">Porkka-Heiskanen T, Kalinchuk A, Alanko L, Urrila A, Stenberg D (2003) Adenosine, energy metabolism, and sleep. Sci World J 3:790&#x2013;798 </citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Franco</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lluis</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Canela</surname>
              <given-names>EI</given-names>
            </name>
            <name>
              <surname>Mallol</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Agnati</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Casado</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Ciruela</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Ferre</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fuxe</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Receptor-receptor interactions involving adenosine A(1) or dopamine D (1) receptors and accessory proteins</article-title>
          <source>J Neural Transm</source>
          <year>2007</year>
          <volume>114</volume>
          <fpage>93</fpage>
          <lpage>104</lpage>
        </citation>
        <citation citation-type="display-unstructured">Franco R, Lluis C, Canela EI, Mallol J, Agnati L, Casado V, Ciruela F, Ferre S, Fuxe K (2007) Receptor-receptor interactions involving adenosine A(1) or dopamine D (1) receptors and accessory proteins. J Neural Transm 114:93&#x2013;104 <pub-id pub-id-type="pmid">17024327</pub-id></citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guttinger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Padrun</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Pralong</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Boison</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Seizure suppression and lack of adenosine A(1) receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts</article-title>
          <source>Exp Neurol</source>
          <year>2005</year>
          <volume>193</volume>
          <fpage>53</fpage>
          <lpage>64</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guttinger M, Padrun V, Pralong WF, Boison D (2005) Seizure suppression and lack of adenosine A(1) receptor desensitization after focal long-term delivery of adenosine by encapsulated myoblasts. Exp Neurol 193:53&#x2013;64 <pub-id pub-id-type="pmid">15817264</pub-id></citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Johansson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Halldner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Dunwiddie</surname>
              <given-names>TV</given-names>
            </name>
            <name>
              <surname>Masino</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Poelchen</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Gimenez-Llort</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Escorihuela</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Fernandesz-Teruel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wiesenfeld-Hallin</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>XJ</given-names>
            </name>
            <name>
              <surname>Hardemark</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Betshotz</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Herlenius</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Fredholm</surname>
              <given-names>BB</given-names>
            </name>
          </person-group>
          <article-title>Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2001</year>
          <volume>98</volume>
          <fpage>9407</fpage>
          <lpage>9412</lpage>
        </citation>
        <citation citation-type="display-unstructured">Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, Escorihuela RM, Fernandesz-Teruel A, Wiesenfeld-Hallin Z, Xu XJ, Hardemark A, Betshotz C, Herlenius E, Fredholm BB (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci USA 98:9407&#x2013;9412 <pub-id pub-id-type="pmid">11470917</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>